Libby Roughead

Research Interests

Clinical Pharmacy and Pharmacy Practice Epidemiology Health Policy Health services and systems Patient safety

Prof Libby Roughead

Bradley Distinguished Professor

School of Pharmacy and Biomedical Science

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

Available For Media Comment.

Hello,  I'm Libby Roughead, a Bradley Distinguished Professor at the University of South Australia and Director of the Quality Use of Medicines and Pharmacy Research Centre. 
Our research focuses on quantifying the extent of problems with medicines use, identifying the extent of harm from medicines, testing solutions for improving medicines use and evaluating improvements in health care.
We work with consumers, health professionals and organisations, ensuring the advanced technologies and methods developed within the centre find their way into policy and practice to improve patient lives.
Our research ranges from large-scale data analysis to the translation of evidence into policy and practice.  
We identify harms from medicines and the effectiveness of different pharmaceutical policies. This research supports policy makers to improve pharmaceutical policy.
We focus on consumer and health professional involvement in all stages of research and test interventions to improve health service delivery to reduce harm and improve outcomes from medicine use . This research has had a direct impact on the Australian health care system, improving patient outcomes. 
We run, on behalf of the Australian Government Department of Veterans' Affairs, the Veterans' Medicines Advice and Therapeutics Education Services (MATES) program. This ongoing program has delivered over 65 therapeutic interventions and targeted every general practioner, pharmacy, aged-care facility and veteran in Australia. The program has led to improvements in medicine use and reductions in hospitalisations.
Our research focuses on 6 key areas: medicines safety, optimising medicine use, digital health, pharmacy practice, Aboriginal traditional medicines, and evidence translation and policy. 
Our PhD students are undertaking research in all areas of medicine use, including developing methods to better detect medicine related harm, pharmacoepidemiology and pharmacovigilance, drug utilisation, testing new models of pharmacy and health care practice; integrating digital health initiatives into health service delivery.   We welcome inquiries for you to join us.

  • Public policy concerning medicines
  • Quality Use of Medicines / Rational Drug Use
  • Pharmacoepidemiology
  • Pharmaceutical Promotion

Date Position Institution name
2025 - ongoing Research Professor University of South Australia
2022 - ongoing Bradley Distinguished Professor University of South Australia

Date Type Title Institution Name Country Amount
2026 Award Bellagio Residence Recipient 2026 Rockefeller Foundation United States -
2025 Achievement Lancet Commissioner on Accelerating Access to Essential Medicines 2025-2027 Lancet Commission United Kingdom -
2019 Award Research Australia Awards Health Services Research Award 2019 Research Australia Australia -
2017 Award Distinguished Investigator Award: Lifetime Achievement. HSRAANZ 2017 Health Services Research Association of Australia & New Zealand Australia -
2016 Fellowship Fellow: International Society of Pharmacoepidemiology 2016 International society for Pharmacoepidemiology United States -
2003 Award Harkness Fellow Commonwealth Fund United States -

Date Institution name Country Title
1995 - 1998 University of South Australia Australia PhD
1993 - 1995 La Trobe University Australia M.App.Sci
1991 - 1992 La Trobe University Australia G. Dip Health Prom & Ed
1981 - 1983 Victorian College of Pharmacy Australia B. Pharm

Year Citation
2025 Mekuria, A. B., Andrade, A. Q., Lim, R., Rowett, D., Hedstrom, M., & Roughead, E. E. (2025). Responsiveness and minimum important change of the Pharmacotherapeutic Symptom Evaluation-20-Australian version: a tool for measuring changes in medicine-related symptoms over time. International Journal Of Clinical Pharmacy, online, 1-12.
DOI
2025 Mekuria, A. B., Lim, R., Andrade, A. Q., Rowett, D., & Roughead, E. E. (2025). Detection of Adverse Medicine Events by Pharmacists in Residential Aged Care Facilities: secondary Analysis of Data From ReMInDAR Trial. Pharmacoepidemiology And Drug Safety, 34(11, article no. e70261), 1-9.
DOI Europe PMC1
2025 Mekuria, A. B., Tegegn, H. G., Andrade, A. Q., Lim, R., Rowett, D., & Roughead, E. E. (2025). Patient reported tools for assessing potential medicine-related symptoms: a systematic review. Research in Social and Administrative Pharmacy, 21(4), 193-204.
DOI Scopus2 WoS2 Europe PMC1
2025 Lim, R., Boord, M., Soriano, J., Bilton, R., & Roughead, E. E. (2025). Monitoring the effects of medications in residential aged care (nursing home) using digital health technologies: insights from the ReMInDAR and ADEPT projects. Age and Ageing, 54(3 article no. afaf019), 1-5.
DOI
2025 Balikubiri, H., Kemp Casey, A., Andrade, A. Q., Marotti, R., Bakker, M., Soriano, J., & Roughead, E. E. (2025). Validation of electronic clinical progress notes for measuring clinical pharmacy performance. Journal Of Pharmacy Practice And Research, online(4), 1-6.
DOI
2025 Balikubiri, H., Kemp Casey, A., Andrade, A. Q., & Roughead, E. E. (2025). Elements of healthcare delivery required to facilitate the clinical governance of hospital pharmacy services: a document review. Health Research Policy And Systems, 23(1, article no.100), 1-11.
DOI
2025 Tan, M. S., Patel, B. K., Roughead, E. E., Ward, M., Reuter, S. E., Roberts, G., & Andrade, A. Q. (2025). Opportunities for clinical decision support targeting medication safety in remote primary care management of chronic kidney disease: a qualitative study in Northern Australia. Journal of Telemedicine and Telecare, 31(5), 656-666.
DOI Scopus1 WoS1 Europe PMC1
2025 Kotwani, A., Chauhan, M., Roughead, E., Muller, A., Escher, M., Huttner, B., & Ivanovska, V. (2025). Overview of Methods for Assessing Antimicrobial Use in Outpatient Settings in High-Income Countries: A Narrative Review. ANTIBIOTICS-BASEL, 14(11), 23 pages.
DOI
2025 Ranwala, R. A. D. L. M. K., Roughead, E. E., Calabretto, J. P., & Andrade, A. Q. (2025). Increasing Prevalence of Long-Term Antidepressant Use in Australia: A Retrospective Observational Study. Pharmacoepidemiology and Drug Safety, 34(11), 10 pages.
DOI Europe PMC1
2025 Gebreyohannes, E. A., Thornton, C., Thiessen, M., de Vries, S. T., Q Andrade, A., Kalisch Ellett, L., . . . Lim, R. (2025). Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project). JMIR Research Protocols, 14, e60084-1-e60084-10.
DOI Scopus1 WoS1 Europe PMC1
2025 Dedefo, M. G., Kassie, G. M., Gebreyohannes, E. A., Lim, R., Roughead, E., & Kalisch Ellett, L. (2025). Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High-Income Countries. Pharmacology Research and Perspectives, 13(4), 9 pages.
DOI
2025 Spinks, J., Mihala, G., Jennings, W., Ware, R. S., Kalisch Ellett, L. M., Roughead, E. E., & Williamson, D. (2025). Potentially preventable medication-related hospitalisations with cardiovascular disease of Aboriginal and Torres Strait Islander people, Queensland, 2013–2017: a retrospective cohort study. Medical Journal of Australia, 222(4), 198-204.
DOI
2025 Dedefo, M. G., Lim, R., Kassie, G. M., Gebreyohannes, E. A., Salekdeh, N. N., Roughead, E., & Kalisch Ellett, L. (2025). Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study. International Journal of Clinical Pharmacy, 47(2), 423-434.
DOI Scopus1 WoS1 Europe PMC1
2025 Dedefo, M. G., Kassie, G. M., Gebreyohannes, E. A., Lim, R., Roughead, E., & Kalisch Ellett, L. (2025). Completeness of spontaneously reported adverse drug reactions in 4 databases. British Journal of Clinical Pharmacology, 91(12), 3389-3400.
DOI Europe PMC1
2025 Chan, A. Y. L., Bahmanyar, S., Beyene, K., Bushnell, G., Gadzhanova, S., & Roughead, E. E. (2025). International trends in opioid prescribing by age and sex from 2001 to 2019: an observational study using population-based databases from 18 countries and one special administrative region. Cns Drugs, 39(11), 1173-1185.
DOI Scopus1
2025 Baruah, U., Page, Z. A., Nguyen, T. B., Pham, T., Nguyen, T. A., Schofield, P., . . . Nguyen, T. A. (2025). Cultural and Linguistic Adaptation of the iSupport for Dementia Program: Perspectives From Vietnamese Carers in Australia. Dementia, 1-24.
DOI
2025 Moore, V., Rumbold, A., Fernandez, R., McElroy, H., Moore, L., Giles, L., . . . Davies, M. (2025). Clomiphene citrate medication for infertility and risk of stillbirth or neonatal death: a population-based cohort study. Journal of Clinical Endocrinology and Metabolism, 110(7), 1818-1827.
DOI WoS1 Europe PMC1
2024 Pham, B. D., Kim, B. G., Esterman, A., Brodaty, H., Kurrle, S., Nguyen, T. B., . . . Nguyen, T. A. (2024). Knowledge, attitudes and self-confidence with skills required for providing dementia care in physicians at primary healthcare settings in Vietnam. BMC Health Services Research, 24(1), 12 pages.
DOI Scopus8 WoS8 Europe PMC6
2024 Dedefo, M. G., Lim, R., Kassie, G. M., Roughead, E., & Ellett, L. K. (2024). Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey. European Journal of Clinical Pharmacology, 80(10), 1543-1554.
DOI Scopus5 WoS5 Europe PMC5
2024 Boord, M. S., Brown, P., Soriano, J., Meola, T., Dumuid, D., Milte, R., . . . Lim, R. (2024). A Digitally Enabled, Pharmacist service to detecT medicine harms in residential aged care (nursing home) (ADEPT): protocol for a feasibility study. BMJ Open, 14(2), e080148.
DOI Scopus3 WoS1 Europe PMC1
2024 Gadzhanova, S., & Roughead, E. (2024). Use of Analgesic and Anti-Inflammatory Medicines before and after Initiation of Biological Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2024(8040681), 7 pages.
DOI Scopus3 WoS3
2024 Banker, T. R., Gillam, M. H., O'Loughlin, P., Rankin, W., Ryan, R., Caruso, C., & Roughead, E. E. (2024). To test or to not test: a retrospective cross-sectional study on potentially inappropriate use of pathology testing in South Australian hospitals. American Journal of Clinical Pathology, 161(4), 342-348.
DOI Scopus2 WoS2 Europe PMC2
2024 Andrade, A. Q., Kerr, M., & Roughead, E. E. (2024). Data-driven interventions for an emergency preparedness system: a national experience in Australia. Studies in Health Technology and Informatics, 310, 1281-1286.
DOI Europe PMC1
2023 Roughead, E. E., & Lim, R. (2023). Preventing overdoses with over-the-counter medicines. Medical Journal of Australia, 218(9), 399-400.
DOI Scopus1 WoS1 Europe PMC1
2023 Lim, R., Bilton, R., Dorj, G., Bereznicki, L., Rowett, D., Ho, J. N., . . . Roughead, E. E. (2023). Pharmacists as patient advocates: a series of case studies illustrating the impacts of a regular pharmacist service in residential aged care (nursing homes). Exploratory research in clinical and social pharmacy, 10(100268), 1-5.
DOI Scopus3 WoS4 Europe PMC3
2023 Nguyen, T. A., Tran, K. V., Hinton, L., Roughead, E. E., Esterman, A., Dang, T. H., . . . Brodaty, H. (2023). Experiences and perceptions of dementia in Vietnam and among the Vietnamese diaspora: a systematic review of qualitative studies. Aging and Mental Health, 27(2), 301-316.
DOI Scopus10 WoS6 Europe PMC5
2023 Andrade, A. Q., Calabretto, J. -P., Pratt, N., Kalisch-Ellett, L., LeBlanc, V. T., & Roughead, E. E. (2023). Precision public health intervention for care coordination: A real world study. British Journal of General Practice, 73(728), e220-1-e220-11.
DOI Scopus1 Europe PMC1
2023 Kumsa, N. B., Kelly, T. -L., Roughead, E. E., Tavella, R., & Gillam, M. H. (2023). Temporal trends in Percutaneous Coronary Intervention in Australia: A retrospective analysis from 2000-2021. Hellenic Journal of Cardiology, 80, 21-30.
DOI Scopus5 WoS4 Europe PMC3
2023 Moffat, A. K., Apajee, J., Le Blanc, V. T., Westaway, K., Andrade, A. Q., Ramsay, E. N., . . . Roughead, E. E. (2023). Reducing opioid use for chronic non-cancer pain in primary care using an evidence-based, theory-informed, multistrategic, multistakeholder approach: A single-arm time series with segmented regression. BMJ Quality and Safety, 32(11), 623-631.
DOI Scopus4 WoS5 Europe PMC6
2023 Kosowicz, L., Tran, K. V., Brodaty, H., Roughead, E., Esterman, A., Hinton, L., . . . Nguyen, T. A. (2023). Vietnam’s Responses to Dementia – An Assessment of Service Delivery. Dementia, 22(7), 1372-1391.
DOI Scopus7 WoS5 Europe PMC5
2023 Andrade, A. Q., Lim, R., Kelly, T. L., Parfitt, G., Pratt, N., & Roughead, E. E. (2023). Wrist accelerometer temporal analysis as a prognostic tool for aged care residents: A sub-study of the ReMInDAR trial. Journal of the American Geriatrics Society, 71(4), 1124-1133.
DOI Scopus2 WoS3 Europe PMC4
2023 Andrade, A. Q., Widagdo, I., Lim, R., Kelly, T. L., Parfitt, G., Pratt, N., . . . Roughead, E. E. (2023). Correlation of frailty assessment metrics in one-year follow-up of aged care residents: a sub-study of a randomised controlled trial. Aging Clinical and Experimental Research, 35(10), 2081-2087.
DOI Scopus1 WoS1 Europe PMC1
2023 Kalisch Ellett, L. M., Dorj, G., Andrade, A. Q., Bilton, R. L., Rowett, D., Whitehouse, J., . . . Roughead, E. E. (2023). Prevalence and preventability of adverse medicine events in a sample of Australian aged-care residents: a secondary analysis of data from the ReMInDAR trial. Drug Safety, 46(5), 493-500.
DOI Scopus4 WoS3 Europe PMC4
2023 Dorj, G., Nair, N. P., Bereznicki, L., Kelly, T. L., Pratt, N., Kalisch-Ellett, L., . . . Roughead, E. (2023). Correction to: Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial (Drugs & Aging, (2023), 40, 1, (49-58), 10.1007/s40266-022-00983-6). Drugs and Aging, 40(1), 89.
DOI
2023 Dorj, G., Nair, N. P., Bereznicki, L., Thu Kelly, L., Pratt, N., Kalisch Ellet, L., . . . Roughead, E. (2023). Risk factors predictive of adverse drug events and drug-related falls in aged care residents: secondary analysis from the ReMInDAR trial. Drugs & Aging, 40(1), 49-58.
DOI Scopus7 WoS8 Europe PMC7
2023 Lim, R., Dumuid, D., Parfitt, G., Stanford, T., Post, D., Bilton, R., . . . Roughead, E. E. (2023). Using wrist-worn accelerometers to identify the impact of medicines with anticholinergic or sedative properties on sedentary time: A 12-month prospective analysis. Maturitas, 172, 9-14.
DOI Scopus7 WoS7 Europe PMC5
2022 Tong, X., Li, X., Pratt, N. L., Hillen, J. B., Stanford, T., Ward, M., . . . Wong, I. C. K. (2022). Monoclonal antibodies and Fc-fusion protein biologic medicines: a multinational cross-sectional investigation of accessibility and affordability in Asia Pacific regions between 2010 and 2020. Lancet Regional Health-Western Pacific, 26(100506), 1-12.
DOI Scopus19 WoS16 Europe PMC14
2022 Hillen, J., Ward, M., Slee, M., Stanford, T., Roughead, E., Kalisch Ellett, L., & Pratt, N. (2022). Utilisation of disease modifying treatment and diversity of treatment pathways in relapsing remitting multiple sclerosis. Multiple Sclerosis and Related Disorders, 57(article no. 103412), 8 pages.
DOI Scopus3 WoS3 Europe PMC3
2022 Man, K. K. C., Shao, S. C., Chaiyakunapruk, N., Dilokthornsakul, P., Kubota, K., Li, J., . . . Lai, E. C. C. (2022). Metabolic events associated with the use of antipsychotics in children, adolescents and young adults: a multinational sequence symmetry study. European Child and Adolescent Psychiatry, 31(1), 99-120.
DOI Scopus10 WoS10 Europe PMC7
2022 Hillen, J. B., Stanford, T., Ward, M., Roughead, E. E., Kalisch-Ellett, L., & Pratt, N. (2022). Rituximab and Pyoderma Gangrenosum: An Investigation of Disproportionality Using a Systems Biology-Informed Approach in the FAERS Database. Drugs Real World Outcomes, 9(4), 639-647.
DOI Scopus3 WoS2 Europe PMC3
2022 Kassie, G. M., Roughead, E. E., Nguyen, T. A., Pratt, N. L., & Kalisch Ellett, L. M. (2022). The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study. Drug Safety, 45(1), 75-82.
DOI Scopus10 WoS10 Europe PMC10
2022 Lim, R., Kelly, T. L., Andrade, A. Q., Kalisch Ellett, L. M., Bilton, R., Dorj, G., . . . Roughead, E. E. (2022). Frailty trajectory over one year among residential aged care (nursing home) residents. Frontiers In Medicine, 9(1010444), 1-8.
DOI Scopus4 WoS4 Europe PMC4
2022 Dorj, G., Lim, R., Ellett, L. K., Kelly, T. L., Andrade, A., Widagdo, I., . . . Roughead, E. (2022). Medicine-related problems: a recurrent issue among residents living in nursing homes. Frontiers In Pharmacology, 13, 1-9.
DOI Scopus1 WoS2 Europe PMC1
2022 Roughead, E. E., Kerr, M., Moffat, A., Kassie, G. M., & Pratt, N. (2022). Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case–Control Study with a Focus on Medicines Used in Primary Care. Drug Safety, 45(11), 1413-1421.
DOI Scopus13 WoS11 Europe PMC11
2022 Lim, R., Ellett, L. K., Roughead, E. E., Cheah, P. Y., & Masnoon, N. (2022). Correction: Lim et al. Patient-Reported Questionnaires to Identify Adverse Drug Reactions: A Systematic Review, (Int. J. Environ. Res. Public Health, (2021), 18, (11877), 10.3390/ijerph182211877). International Journal of Environmental Research and Public Health, 19(18), 1 page.
DOI Scopus1 WoS2
2022 Lim, R., Ellett, L. M. K., Semple, S., & Roughead, E. E. (2022). The extent of medication-related hospital admissions in Australia: a review from 1988 to 2021. Drug Safety, 45(3), 249-257.
DOI Scopus78 WoS73 Europe PMC58
2022 Kelly, T. L., Ward, M., Pratt, N. L., Ramsay, E., Gillam, M., & Roughead, E. E. (2022). The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians. Respiratory Research, 23(1), 11 pages.
DOI Scopus3 WoS3 Europe PMC3
2022 Roughead, E. E., Ramsay, E. N., Kalisch Ellett, L. M., Khoo, A., Moffatt, A., & Pratt, N. L. (2022). Variation in health service use by veterans with an accepted disability of post-traumatic stress disorder who had a service record post 1975: A cluster analysis. BMJ Military Health, 168(1), 76-81.
DOI Scopus1 WoS1
2022 Shute, R., Blacker, N., Dias, M., Frank, O., & Roughead, E. (2022). Changing the way we treat tinnitus. Journal Of Military And Veterans Health, 31(1), 32-39.
2022 Van Tran, K., Esterman, A., Saito, Y., Brodaty, H., Vu, N. C., Roughead, E., . . . Nguyen, T. A. (2022). Factors associated with high rates of depressive symptomatology in older people in Vietnam. American Journal Of Geriatric Psychiatry, 30(8), 892-902.
DOI Scopus11 WoS8 Europe PMC5
2022 Roughead, E. E., Pratt, N. L., Parfitt, G., Rowett, D., Kalisch-Ellett, L. M., Bereznicki, L., . . . Lim, R. (2022). Effect of an ongoing pharmacist service to reduce medicine-induced deterioration and adverse reactions in aged-care facilities (nursing homes): a multicentre, randomised controlled trial (the ReMInDAR trial). AGE AND AGEING, 51(4), 1-9.
DOI Scopus25 WoS21 Europe PMC25
2022 Moore, V., Rumbold, A., Fernandez, R., McElroy, H., Moore, L., Giles, L., . . . Davies, M. (2022). Dispensing of clomiphene citrate to treat infertility: medication supplied and population prevalence of assisted pregnancies and multiple births. Fertility and Sterility, 117(1), 202-212.
DOI Scopus4 WoS4 Europe PMC4
2022 Gillam, M. H., Pratt, N. L., Inacio, M. C. S., Shakib, S., Caughey, G. E., Sanders, P., . . . Roughead, E. E. (2022). Cardiac implantable electronic devices: reoperations and the competing risk of death. Heart Lung and Circulation, 31(4), 537-543.
DOI
2022 Andrade, A. Q., Calabretto, J. -P., Pratt, N. L., Kalisch-Ellett, L. M., Kassie, G. M., LeBlanc, V. T., . . . Roughead, E. E. (2022). Implementation and Evaluation of a Digitally Enabled Precision Public Health Intervention to Reduce Inappropriate Gabapentinoid Prescription: Cluster Randomized Controlled Trial. Journal of Medical Internet Research, 24(1), e33873-1-e33873-12.
DOI Scopus5 WoS6 Europe PMC6
2022 Morrow, R. L., Mintzes, B., Souverein, P. C., De Bruin, M. L., Roughead, E. E., Lexchin, J., . . . Dormuth, C. R. (2022). Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ Quality and Safety, 31(3), 179-190.
DOI Europe PMC7
2022 Morrow, R. L., Mintzes, B., Souverein, P. C., Hallgreen, C. E., Ahmed, B., Roughead, E. E., . . . Dormuth, C. R. (2022). Hydroxyzine initiation following drug safety advisories on cardiac arrhythmias in the UK and Canada: a longitudinal cohort study. Drug Safety, 45(6), 623-638.
DOI Europe PMC1
2022 Kemp Casey, A., Mintzes, B., Morrow, R. L., Dormuth, C. R., Souverein, P. C., & Roughead, E. E. (2022). Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: an interrupted time series study. Pharmacoepidemiology And Drug Safety, 31(10), 1039-1045.
DOI Europe PMC3
2021 Seaman, K., Sanfilippo, F., Bulsara, M., Roughead, E., Kemp Casey, A., Bulsara, C., . . . Preen, D. (2021). Increased risk of 2-year death in patients who discontinued their use of statins. Journal of Health Services Research and Policy, 26(2), 95-105.
DOI Europe PMC2
2021 Seaman, K. L., Bulsara, M. K., Sanfilippo, F. M., Kemp Casey, A., Roughead, E. E., Bulsara, C., . . . Preen, D. B. (2021). Exploring the association between stroke and acute myocardial infarction and statins adherence following a medicines co-payment increase. Research in Social and Administrative Pharmacy, 17(10), 1780-1785.
DOI Europe PMC2
2021 Kalisch Ellett, L. M., Kassie, G. M., Caughey, G. E., Pratt, N. L., Ramsay, E. N., & Roughead, E. E. (2021). Medication-related hospital admissions in aged care residents. Australasian journal on ageing, 40(4), e323-e331.
DOI Scopus10 WoS10 Europe PMC10
2021 Gillam, M. H., Roughead, E., Tavella, R., Dodd, T., Beltrame, J., Ryan, R., & O'Loughlin, P. (2021). The impact of COVID-19 restrictions on pathology service utilisation.. Internal medicine journal, 52(1), 42-48.
DOI Scopus4 WoS5 Europe PMC5
2021 Bidargaddi, N., Schrader, G., Myles, H., Schubert, K. O., van Kasteren, Y., Zhang, T., . . . Strobel, J. (2021). Demonstration of automated non-adherence and service disengagement risk monitoring with active follow-up for severe mental illness. Australian and New Zealand Journal of Psychiatry, 55(10), 976-982.
DOI Scopus13 WoS11 Europe PMC8
2021 De Vries, C., Gadzhanova, S., Sykes, M. J., Ward, M., & Roughead, E. (2021). A systematic review and meta-analysis considering the risk for congenital heart defects of antidepressant classes and individual antidepressants. Drug Safety, 44(3), 291-312.
DOI Scopus42 WoS34 Europe PMC23
2021 Kalisch Ellett, L. M., Kassie, G. M., Ramsay, E. N., Pratt, N. L., & Roughead, E. E. (2021). Evaluation of Renal Function Testing in Older Australian Veterans Dispensed Medicines that Require Renal Function Monitoring. Drugs and Aging, 38(11), 995-1002.
DOI Scopus1 WoS1 Europe PMC1
2021 Lim, R., Kalisch Ellett, L., Roughead, E. E., Cheah, P. Y., & Masnoon, N. (2021). Patient-reported questionnaires to identify adverse drug reactions: a systematic review. International Journal of Environmental Research and Public Health, 18(22, article no. 11877), 1-17.
DOI Scopus17 WoS17 Europe PMC16
2021 Lee, H. J., Roughead, E. E., Han, E., Lee, J., & Kalisch Ellett, L. (2021). Post-market utilization patterns of Alzheimer’s disease treatments in South Korea: comparison with countries with universal health coverage. European Journal of Clinical Pharmacology, 77(6), 921-929.
DOI Scopus5 WoS5 Europe PMC5
2021 Leach, M. J., Roughead, E. E., & Pratt, N. L. (2021). A data visualisation method for assessing exposure misclassification in case-crossover studies: the example of tricyclic antidepressants and the risk of hip fracture in older people. BMC Medical Research Methodology, 21(1, article no. 43, pp. 1-7), 7 pages.
DOI Scopus3 WoS2 Europe PMC2
2021 Kubota, K., Kelly, T. L., Sato, T., Pratt, N., Roughead, E., & Yamaguchi, T. (2021). A novel weighting method to remove bias from within-subject exposure dependency in case-crossover studies. BMC Medical Research Methodology, 21(1, article no. 214), 1-13.
DOI Scopus10 WoS10 Europe PMC9
2021 Pratt, N. L., Ellett, L. M. K., Andrade, A. Q., Le Blanc, V. T., Barratt, J., & Roughead, E. E. (2021). Prevalence of multiple risk factors for poor outcomes associated with COVID-19 among an elderly Australian population. Australian Journal of General Practice, 50(1-2), 84-89.
DOI Scopus4 WoS3 Europe PMC3
2020 Kalisch Ellett, L. M., Pratt, N. L., Nguyen, T. A., & Roughead, E. E. (2020). Use of health and support services by people living with dementia in the community setting. Australasian Journal on Ageing, 39(4), 341-349.
DOI Scopus4 WoS5 Europe PMC2
2020 Moffat, A. K., Apajee, J., Pratt, N. L., Blacker, N., Le, B. V. T., & Roughead, E. E. (2020). Use of medicines associated with dry mouth and dental visits in an Australian cohort. Australian Dental Journal, 65(3), 189-195.
DOI Scopus4 WoS4 Europe PMC3
2020 Andrade, A. Q., LeBlanc, V. T., Kalisch Ellett, L. M., Pratt, N. L., Moffat, A., Blacker, N., . . . Roughead, E. E. (2020). Determinants of usefulness in professional behaviour change interventions: observational study of a 15-year national program. BMJ open, 10(10), 1-8.
DOI Scopus3 WoS4 Europe PMC3
2020 Kalisch Ellett, L. M., Kemp-Casey, A., Kassie, G. M., Pratt, N. L., & Roughead, E. E. (2020). Use of analgesics following rescheduling of codeine in Australia: An interrupted time series analysis in the veteran population. International Journal of Drug Policy, 81, 7 pages.
DOI Scopus7 WoS7 Europe PMC5
2020 Zhan, C., Roughead, E., Liu, L., Pratt, N., & Li, J. (2020). Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data. Journal of Biomedical Informatics, 112(article no. 103603), 13 pages.
DOI Scopus14 WoS12 Europe PMC9
2020 Zhan, C., Roughead, E., Liu, L., Pratt, N., & Li, J. (2020). Detecting potential signals of adverse drug events from prescription data. Artificial Intelligence in Medicine, 104(101839), 14 pages.
DOI Scopus11 WoS9 Europe PMC9
2020 Moffat, A. K., Pratt, N. L., Ellett, L. M. K., Ramsay, E. N., & Roughead, E. E. (2020). Comorbidities in an Australian sample of chronic and new opioid users. Journal of Opioid Management, 16(2), 103-110.
DOI Scopus1 Europe PMC1
2020 Moffat, A. K., Pratt, N. L., Kerr, M., Ellett, L. M. K., & Roughead, E. E. (2020). Risk of chronic opioid use in older persons with pre-existing anxiety. Journal of Opioid Management, 16(1), 59-66.
DOI Scopus3 Europe PMC3
2020 Parfitt, G., Post, D., Ellett, L. K., Lim, R., Penington, A., Corlis, M., & Roughead, E. (2020). A cross-sectional assessment of the relationship between sedative medication and anticholinergic medication use and the movement behaviour of older adults living in residential aged care. Peerj, 8(e9605), 9 pages.
DOI Scopus2 WoS2 Europe PMC2
2020 Gadzhanova, S., Roughead, E., Lowy, H., & O'Connor, D. (2020). Reducing adverse medication events in mental health: Australian National Survey. International journal of evidence-based healthcare, 18(1), 108-115.
DOI Scopus3 WoS3 Europe PMC2
2020 Gadzhanova, S., Gillam, M., & Roughead, E. (2020). Risk of falls and injuries requiring hospitalisation after first-eye cataract surgery in elderly Australians. Acta Ophthalmologica, 98(4), e495-e498.
DOI Scopus5 WoS4 Europe PMC4
2020 Lim, R., Bereznicki, L., Corlis, M., Kalisch Ellett, L. M., Kang, A. C., Merlin, T., . . . Roughead, E. E. (2020). Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome.. BMJ Open, 10(4), e032851.
DOI Scopus12 WoS12 Europe PMC11
2020 Moffat, A. K., Westaway, K. P., Apajee, J., Frank, O., Shute, R., Weston, C., . . . Roughead, E. E. (2020). Impact of a patient-specific national programme aimed at increasing the use of emollient moisturisers to reduce the risk of skin tears: a longitudinal cohort study.. BMJ open, 10(10), e039579.
DOI WoS1 Europe PMC1
2020 Seaman, K. L., Sanfilippo, F. M., Bulsara, M. K., Brett, T., Kemp Casey, A., Roughead, E. E., . . . Preen, D. B. (2020). Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase. Australian Health Review, 44(3), 377-384.
DOI Europe PMC1
2020 Nguyen, T. A., Pham, T., Dang, T. H., Hinton, W. L., Nguyen, A. T., Pham, T. L., . . . Roughead, E. E. (2020). Towards the development of Vietnam's national dementia plan--the first step of action. Australasian Journal on Ageing, 39(2), 137-141.
DOI Scopus28 WoS34 Europe PMC22
2020 Seaman, K., Sanfilippo, F., Bulsara, M., Roughead, L., Kemp Casey, A., Bulsara, C., . . . Preen, D. (2020). Predictors of ceasing or reducing statin medication following a large medication consumer co-payment increase: A retrospective observation study.. Public Health Research and Practice, 30(1, article no. e29121905), 1-9.
DOI Europe PMC7
2020 Westaway, K., Sluggett, J., Alderman, C., Moffat, A., Procter, N. G., & Roughead, E. (2020). The extent of antipsychotic use in Australian residential aged care facilities and interventions shown to be effective in reducing antipsychotic use: A literature review. Dementia, 19(4), 1189-1202.
DOI Scopus24 WoS25 Europe PMC19
2019 Laba, T. L., Reddel, H. K., Zwar, N. J., Marks, G. B., Roughead, E., Flynn, A., . . . Jan, S. (2019). Does a patient-directed financial incentive affect patient choices about controller medicines for asthma? A discrete choice experiment and financial impact analysis. PharmacoEconomics, 37(2), 227-238.
DOI Europe PMC3
2019 Tudball, J., Reddel, H. K., Laba, T. L., Jan, S., Flynn, A., Goldman, M., . . . Zwar, N. (2019). General practitioners' views on the influence of cost on the prescribing of asthma preventer medicines: A qualitative study. Australian health review, 43(3), 246-253.
DOI Europe PMC3
2019 Kemp Casey, A., Ceria Perena, J., Guerrero, A. M., Suchonwanich, N., Salleh, S. M., & Roughead, E. E. (2019). Follow-up data on patent expiry and atorvastatin price: experiences in Brunei Darussalam, Malaysia, the Philippines and Thailand. WHO South-East Asia Journal of Public Health, 8(2), 115-117.
DOI
2019 Andrade, A. Q., & Roughead, E. E. (2019). Consumer-directed technologies to improve medication management and safety. Medical journal of Australia, 210(6), 24-27.
DOI Europe PMC4
2019 Laba, T. L., Jan, S., Zwar, N. A., Roughead, E., Marks, G. B., Flynn, A. W., . . . Reddel, H. K. (2019). Cost-related underuse of medicines for asthma-opportunities for improving adherence. Journal of allergy and clinical immunology: in practice, 7(7), 2298.e12-2306.e12.
DOI Europe PMC25
2019 Kalisch Ellett, L. M., Moffat, A. K., Gadzhanova, S., Pratt, N. L., Apajee, J., Woodward, M., & Roughead, E. E. (Eds.) (2019). Reduction in use of risperidone for dementia in Australia following changed guidelines. Pharmacy, 7(3), 1-11.
2019 Pratt, N. L., Ramsay, E., Kalisch Ellett, L. M., Duszynski, K., Shakib, S., Kerr, M., . . . Roughead, E. E. (2019). Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study. BMJ Open, 9(5), e026486.
DOI Scopus9 WoS9 Europe PMC7
2019 Westaway, K., Blacker, N., Shute, R., Allin, R., Elgebaly, Z., Frank, O., . . . Roughead, E. (2019). Combination psychotropic medicine use in older adults and risk of hip fracture. Australian Prescriber, 42(3), 93-96.
DOI Scopus9 WoS8 Europe PMC7
2019 Duszynski, K. M., Pratt, N. L., Lynch, J. W., Braunack-Mayer, A., Taylor, L. K., Berry, J. G., . . . Gold, M. S. (2019). Process trumps potential public good: better vaccine safety through linked cross-jurisdictional immunisation data in Australia. Australian and New Zealand Journal of Public Health, 43(5), 496-503.
DOI Scopus11 WoS10 Europe PMC7
2019 Roughead, E. E., Lim, R., Ramsay, E., Moffat, A., & Pratt, N. (2019). Persistence with opioids post discharge from hospitalisation for surgery in Australian adults: a retrospective cohort study. BMJ open, 9(4, article no. e023990), 1-6.
DOI Scopus29 WoS30 Europe PMC22
2019 Ellett, L. M. K., Moffat, A. K., Gadzhanova, S., Pratt, N. L., Apajee, J., Woodward, M., & Roughead, E. E. (2019). Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines. PHARMACY, 7(3), 11 pages.
DOI WoS6 Europe PMC7
2019 Kassie, G. M., Kalisch Ellett, L. M., Nguyen, T. A., & Roughead, E. E. (2019). Use of medicines that may precipitate delirium prior to hospitalisation in older Australians with delirium: An observational study. Australasian Journal on Ageing, 38(2), 124-131.
DOI Scopus11 WoS10 Europe PMC10
2019 Gillam, M. H., Kerr, M., Pratt, N. L., Lim, R., & Roughead, E. E. (2019). Mesh use in urogynaecological procedures between 2005 and 2016: an Australian cohort study. Australian and New Zealand journal of obstetrics and gynaecology, 59(1), 105-109.
DOI Scopus4 WoS4 Europe PMC3
2019 Lim, R., Kalisch Ellett, L. M., Widagdo, I. S., Pratt, N. L., & Roughead, E. E. (2019). Analysis of anticholinergic and sedative medicine effects on physical function, cognitive function, appetite and frailty: A cross-sectional study in Australia. BMJ Open, 9(9), 9 pages.
DOI Scopus33 WoS31 Europe PMC25
2019 Ellett, L. M. K., Kassie, G. M., Pratt, N. L., Kerr, M., & Roughead, E. E. (2019). Prevalence and Duration of Use of Medicines Recommended for Short-Term Use in Aged Care Facility Residents. PHARMACY, 7(2), 11 pages.
DOI WoS7 Europe PMC7
2019 Preiss, A. K., Roughead, E. E., & Pratt, N. L. (2019). Sequence symmetry analysis graphic adjustment for prescribing trends. BMC medical research methodology, 19(1, article no.143), 1-12.
DOI Scopus7 WoS6 Europe PMC6
2019 Kalisch Ellett, L. M., Pratt, N. L., Apajee, J., & Roughead, E. E. (2019). Initiation and continuation of antipsychotic medicines in older people following non-psychiatric hospital admission. International Journal of Clinical Pharmacy, 41(5), 1341-1347.
DOI Scopus6 WoS6 Europe PMC3
2019 Kemp-Casey, A., Pratt, N., Ramsay, E., & Roughead, E. E. (2019). Using post-market utilisation analysis to support medicines pricing policy: an Australian case study of aflibercept and ranibizumab use. Applied Health Economics and Health Policy, 17(3), 411-417.
DOI Scopus6 WoS6 Europe PMC5
2019 Rasmussen, L., Pratt, N., Roughead, E., & Moffat, A. (2019). Prevalence of psychotropic medicine use in Australian children with autism spectrum disorder: a drug utilization study based on children enrolled in the longitudinal study of Australian children. Journal of Autism and Developmental Disorders, 49(1), 227-235.
DOI Scopus14 WoS13 Europe PMC10
2019 Duszynski, K. M., Pratt, N. L., Lynch, J. W., Berry, J. G., & Gold, M. S. (2019). Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and the National Death Index. Vaccine, 37(2), 280-288.
DOI Scopus3 WoS3 Europe PMC3
2019 Caughey, G. E., Gadzhanova, S., Shakib, S., & Roughead, E. E. (2019). Concomitant prescribing of opioids and benzodiazepines in Australia, 2012–2017. Medical Journal of Australia, 210(1), 39-40.
DOI Scopus9 WoS9 Europe PMC7
2019 Caughey, G. E., Shakib, S., Barratt, J. D., & Roughead, E. E. (2019). Use of medicines that may exacerbate heart failure in older adults: therapeutic complexity of multimorbidity. Drugs and Aging, 36(5), 471-479.
DOI Scopus10 WoS10 Europe PMC9
2018 Nguyen, T. A., Knight, R., Mant, A., Razee, H., Brooks, G., Dang, T. H., & Roughead, E. E. (2018). Corruption practices in drug prescribing in Vietnam - an analysis based on qualitative interviews. BMC health services research, 18(1, article no. 587), 1-20.
DOI Scopus16 WoS11 Europe PMC6
2018 Hoang, T., Liu, J., Pratt, N., Zheng, V. W., Chang, K. C., Roughead, E., & Li, J. (2018). Authenticity and credibility aware detection of adverse drug events from social media. International journal of medical informatics, 120, 157-171.
DOI Scopus5 WoS4 Europe PMC6
2018 Inacio, M., Cashman, K., Pratt, N., Gillam, M., Caughey, G., Graves, S., & Roughead, E. (2018). Prevalence and changes in analgesic medication utilisation 1 year prior to total joint replacement in an older cohort of patients. Osteoarthritis and Cartilage, 26(3), 356-362.
DOI Scopus25 WoS24 Europe PMC18
2018 Hoang, T., Liu, J., Roughead, E., Pratt, N., & Li, J. (2018). Supervised signal detection for adverse drug reactions in medication dispensing data. Computer Methods and Programs in Biomedicine, 161, 25-38.
DOI Scopus29 WoS23 Europe PMC19
2018 Poh, E. W., McArthur, A., Stephenson, M., & Roughead, E. E. (2018). Effects of pharmacist prescribing on patient outcomes in the hospital setting: A systematic review. JBI database of systematic reviews and implementation reports, 16(9), 1823-1873.
DOI Scopus27 Europe PMC22
2018 Gillam, M., Pratt, N., Inacio, M., Shakib, S., Sanders, P., Lau, D., & Roughead, E. (2018). Rehospitalizations for complications and mortality following pacemaker implantation: a retrospective cohort study in an older population. Clinical Cardiology, 41(11), 1480-1486.
DOI Scopus15 WoS14 Europe PMC11
2018 Raman, S. R., Man, K. K. C., Bahmanyar, S., Berard, A., Bilder, S., Boukhris, T., . . . Wong, I. C. K. (2018). Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. The Lancet Psychiatry, 5(10), 824-835.
DOI Scopus258 WoS246 Europe PMC196
2018 Kalisch Ellett, L. M., Lim, R., Pratt, N. L., Kerr, M., Ramsay, E. N., Leblanc, T. V., . . . Roughead, E. E. (2018). Reducing hypnotic use in insomnia management among Australian veterans: Results from repeated national interventions. BMC Health Services Research, 18(1), 626.
DOI Scopus4 WoS4 Europe PMC4
2018 Hoang, T., Liu, J., Pratt, N., Zheng, V. W., Chang, K. C., Roughead, E., & Li, J. (2018). Authenticity and credibility aware detection of adverse drug events from social media. International Journal of Medical Informatics, 120, 157-171.
DOI Scopus10 WoS5 Europe PMC2
2018 Widagdo, I. S., Pratt, N. L., & Roughead, E. E. (2018). The association between frailty and medicines use over time: an analysis using the Australian Longitudinal Study on Ageing population. Journal of Pharmacy Practice and Research, 48(5), 405-415.
DOI
2018 Lai, E. C. C., Shin, J. Y., Kubota, K., Man, K. K. C., Park, B. J., Pratt, N., . . . Setoguchi, S. (2018). Comparative safety of NSAIDs for gastrointestinal events in Asia-Pacific populations: a multi-database, international cohort study. Pharmacoepidemiology and drug safety, 27(11), 1223-1230.
DOI Scopus12 WoS11 Europe PMC9
2018 Gillam, M., Inacio, M., Pratt, N., Shakib, S., & Roughead, E. (2018). Magnetic Resonance Imaging in People With Cardiac Implantable Electronic Devices: A Population Based Cohort Study. Heart Lung and Circulation, 27(6), 748-751.
DOI Scopus6 WoS6 Europe PMC5
2018 Westaway, K., Frank, O., Shute, R., Moffat, A., LeBlanc, V., Rowett, D., . . . Roughead, E. (2018). Gathering tips from carers to support people with dementia: an adaptation of the TOP 5 program for community use. International Journal of Evidence-Based Healthcare, 16(2), 128-135.
DOI Scopus2 WoS2 Europe PMC2
2018 Robinson, M., Mihalopoulos, C., Merlin, T., & Roughead, E. (2018). Characteristics of managed entry agreements in Australia. International Journal of Technology Assessment in Health Care, 34(1), 46-55.
DOI Scopus22 WoS18 Europe PMC14
2018 Nguyen, T. A., Pham, T., Vu, H. T. T., Nguyen, T. X., Vu, T. T., Nguyen, B. T. T., . . . Roughead, E. E. (2018). Use of potentially inappropriate medications in people with dementia in Vietnam and its associated factors. American Journal of Alzheimer's Disease and other Dementias, 33(7), 423-432.
DOI Scopus17 WoS14 Europe PMC11
2018 Pratt, N., & Roughead, E. (2018). Assessment of Medication Safety Using Only Dispensing Data. CURRENT EPIDEMIOLOGY REPORTS, 5(4), 357-369.
DOI WoS13 Europe PMC12
2018 Kalisch Ellett, L., Pratt, N., & Roughead, E. (2018). Analgesic use in Vietnam veterans' with musculoskeletal pain. Journal of military and veterans' health, 26(3), 28-35.
WoS1
2018 Kassie, G. M., Kalisch Ellett, L. M., Nguyen, T. A., & Roughead, E. E. (2018). Knowledge of Australian hospital pharmacists regarding delirium in elderly patients. Journal of Pharmacy Practice and Research, 48(2), 116-123.
DOI Scopus3
2018 Ramsay, E., Pratt, N., Moffat, A., Kalisch Ellett, L., & Roughead, E. (2018). Evaluating the assumptions of the self-controlled case series design in studies investigating the risks of antipsychotic use in the older population. Pharmacoepidemiology and drug safety, 27(S2, article no. 776), 354-355.
DOI
2018 Pratt, N., Kerr, M., Barratt, J., Kemp Casey, A., Kalisch Ellett, L., Ramsay, E., & Roughead, E. (2018). The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System. BMJ open, 8(4), 1-8.
DOI Scopus227 WoS228 Europe PMC195
2018 Gadzhanova, S., Roughead, E. E., & Pont, L. G. (2018). Antidepressant switching patterns in the elderly. International psychogeriatrics, 30(9), 1365-1374.
DOI Scopus10 WoS8 Europe PMC6
2018 Kalisch Ellett, L. M., Pratt, N. L., Kerr, M., & Roughead, E. E. (2018). Antipsychotic polypharmacy in older Australians. International Psychogeriatrics, 30(4), 539-546.
DOI Scopus8 WoS9 Europe PMC6
2018 Kassie, G. M., Nguyen, T. A., Kalisch Ellett, L. M., Pratt, N. L., & Roughead, E. E. (2018). Do risk prediction models for postoperative delirium consider patients' preoperative medication use?. Drugs and aging, 35(3), 213-222.
DOI Scopus12 WoS12 Europe PMC10
2018 Bartlett, L. E., Pratt, N., & Roughead, E. E. (2018). Does a fixed-dose combination of amlodipine and atorvastatin improve persistence with therapy in the Australian population?. Current Medical Research and Opinion, 34(2), 305-311.
DOI Scopus7 WoS7 Europe PMC7
2018 Namba, R. S., Inacio, M. C. S., Pratt, N. L., Graves, S. E., Roughead, E. E., & Paxton, E. W. (2018). Persistent opioid use following total knee arthroplasty: a signal for close surveillance. Journal of arthroplasty, 33(2), 331-336.
DOI Scopus62 WoS55 Europe PMC49
2018 Zhan, C., Roughead, E., Liu, L., Pratt, N., & Li, J. (2018). A data-driven method to detect adverse drug events from prescription data. Journal of Biomedical Informatics, 85, 10-20.
DOI Scopus9 WoS8 Europe PMC6
2018 Kalisch Ellett, L. M., Pratt, N. L., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2018). Sustaining practice change in health care: the impact of a national quality improvement program on the uptake of collaborative medicines reviews. Journal of pharmacy practice and research, 48(3), 222-230.
DOI Scopus7
2018 Bartlett, L. E., Pratt, N. L., & Roughead, E. E. (2018). Prior experience with cardiovascular medicines predicted longer persistence in people initiated to combinations of antihypertensive and lipid-lowering therapies: findings from two Australian cohorts. Patient preference and adherence, 12, 835-843.
DOI Scopus3 WoS3 Europe PMC3
2018 Soleymani, F., Taheri, F., Roughead, E., Nikfar, S., & Abdollahi, M. (2018). Pattern of antidepressant utilization and cost in Iran from 2006 to 2013 in comparison with other countries. Journal of epidemiology and global health, 8(3-4), 213-219.
DOI Europe PMC8
2018 Nguyen, T. A., Dang, T. H., Garrido, S., & a, L. (2018). P3‐536: quality use of medicines in people with Dementia: where to go from here. Alzheimer S & Dementia, 14(7S), 1328.
DOI
2018 Roughead, E. E., Kim, D. S., Ong, B., & Kemp Casey, A. (2018). Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price. WHO South-East Asia journal of public health, 7(2), 99-106.
DOI Europe PMC13
2018 Gadzhanova, S., Roughead, E., & Bartlett, L. (2018). Utilisation of medicines for treatment of multiple myeloma in Australia. Pharmacoepidemiology and drug safety, 27(S2), 432.
2018 Sriskandarajah, S., Hobbs, J., Roughead, E., Ryan, M., & Reynolds, K. (2018). Safety and effectiveness of 'hospital in the home' and 'outpatient parenteral antimicrobial therapy' in different age groups: A systematic review of observational studies. International journal of clinical practice, 72(8, article no. e13216), 1-15.
DOI Europe PMC26
2018 Lim, R., Kerr, M., & Roughead, E. E. (2018). Use of medicines and health services for chronic obstructive pulmonary disease among a cohort of Australians over 50 years. International journal of chronic obstructive pulmonary disease, 2018(13), 3085-3093.
DOI Scopus3 WoS3 Europe PMC3
2017 Seaman, K. L., Sanfilippo, F. M., Roughead, E. E., Bulsara, M. K., Kemp Casey, A., Bulsara, C., . . . Preen, D. (2017). Impact of consumer copayments for subsidised medicines on health services use and outcomes: a protocol using linked administrative data from Western Australia. BMJ open, 7(6, article no. e013691), 1-7.
DOI
2017 Lopez, D., Kemp, C. A., Saunders, C., Roughead, E., Boyle, F., Bulsara, M., & Preen, D. (2017). Clinical consultations and investigations before and after discontinuation of endocrine therapy in women with primary breast cancer. Public health research and practice, 27(3, article no. e2731726), 1-7.
DOI
2017 Robinson, M. F., & Roughead, E. (2017). Characteristics of managed access agreements for medicines in Australia. Value in health, 20(5), 65.
2017 Kemp Casey, A., Roughead, E. E., Saunders, C., Boyle, F., Bulsara, M., & Preen, D. B. (2017). Switching between endocrine therapies for primary breast cancer: frequency and timing in Australian clinical practice. Asia-Pacific journal of clinical oncology, 13(2), e161-e170.
DOI Europe PMC4
2017 Kjosavik, S. R., Gillam, M. H., & Roughead, E. E. (2017). Average duration of treatment with antipsychotics among concession card holders in Australia. Australian & New Zealand journal of psychiatry, 51(7), 719-726.
DOI Scopus5 WoS4 Europe PMC4
2017 Leach, M. J., Pratt, N. L., & Roughead, E. E. (2017). Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case–Control Study in Australia. Drugs - Real World Outcomes, 4(2), 87-96.
DOI Scopus14 Europe PMC11
2017 Kassie, G. M., Nguyen, T. A., Kalisch Ellett, L. M., Pratt, N. L., & Roughead, E. E. (2017). Preoperative medication use and postoperative delirium: a systematic review. BMC geriatrics, 17(article no. 298), 1-10.
DOI Scopus99 WoS85 Europe PMC72
2017 Kassie, G. M., Kalisch Ellett, L. M., Nguyen, T. A., & Roughead, E. E. (2017). Current practice and opinions of hospital pharmacists regarding their role in the screening, prevention and treatment of delirium. International Journal of Clinical Pharmacy, 39(6), 1194-1200.
DOI Scopus7 WoS7 Europe PMC5
2017 Nguyen, T. A., Knight, R., Mant, A., Razee, H., Brooks, G., Dang, T. H., & Roughead, E. E. (2017). Inflated medicine prices in Vietnam. Health policy and planning, 32(5), 647-656.
DOI Scopus15 WoS12
2017 Gillam, M., Pratt, N., Inacio, M., Roughead, E., Shakib, S., Nicholls, S., & Graves, S. (2017). Heart failure after conventional metal-on-metal hip replacements: a retrospective cohort study. Acta Orthopaedica, 88(1), 2-9.
DOI Scopus26 WoS25 Europe PMC24
2017 Hansen, C., Inacio, M., Pratt, N., Roughead, E., & Graves, S. (2017). Chronic use of opioids before and after total knee arthroplasty: a retrospective cohort study. Journal of Arthroplasty, 32(3), 811-817.e1.
DOI Scopus100 WoS95 Europe PMC76
2017 Caughey, G., Pratt, N., Barratt, J., Shakib, S., Kemp-Casey, A., & Roughead, E. (2017). Understanding 30-day re-admission after hospitalisation of older patients for diabetes: Identifying those at greatest risk. Medical Journal of Australia, 206(4), 170-175.
DOI Scopus26 WoS24 Europe PMC19
2017 Caughey, G. E., Barratt, J. D., Shakib, S., Kemp-Casey, A., & Roughead, E. E. (2017). Medication use and potentially high-risk prescribing in older patients hospitalized for diabetes: a missed opportunity to improve care?. Diabetic Medicine, 34(3), 432-439.
DOI Scopus17 WoS15 Europe PMC12
2017 Pratt, N. L., & Roughead, E. E. (2017). Can we reduce the prevalence of persistent opioid use after surgery by predicting the future?. Anaesthesia and intensive care, 45(6), 658-659.
DOI Scopus1 WoS1
2017 Leach, M. J., Pratt, N. L., & Roughead, E. E. (2017). The risk of hip fracture due to mirtazapine exposure when switching antidepressants or using other antidepressants as add-on therapy. Drugs - real world outcomes, 4(4), 247-255.
DOI Scopus11 Europe PMC9
2017 Khalil, H., & Roughead, L. (2017). Medication safety programs in primary care: a scoping review protocol. JBI database of systematic reviews and implementation reports, 15(6), 1512-1517.
DOI Scopus6 Europe PMC3
2017 Khalil, H., Shahid, M., & Roughead, L. (2017). Medication safety programs in primary care: a scoping review. JBI database systematic reviews and implement reports, 15(10), 2512-2526.
DOI Scopus17 Europe PMC8
2017 Gadzhanova, S., Pratt, N., & Roughead, E. (2017). Use of SGLT2 inhibitors for diabetes and risk of infection: Analysis using general practice records from the NPS MedicineWise MedicineInsight program. Diabetes Research and Clinical Practice, 130, 180-185.
DOI Scopus50 WoS48 Europe PMC45
2017 Inacio, M. C. S., Graves, S. E., Pratt, N. L., Roughead, E. E., & Nemes, S. (2017). Increase in total joint arthroplasty projected from 2014 to 2046 in Australia: a conservative local model with international implications. Clinical Orthopaedics and Related Research, 475(8), 2130-2137.
DOI Scopus171 WoS153 Europe PMC125
2017 Kalisch Ellett, L. M., Pratt, N. L., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2017). Patient-specific prescriber feedback can increase the rate of osteoporosis screening and treatment: results from two national interventions. Archives of osteoporosis, 12(1, article no. 17), 1-7.
DOI Scopus6 WoS6 Europe PMC5
2017 Roughead, E. E., Pratt, N. L., Kalisch Ellett, L. M., Ramsay, E. N., Barratt, J. D., Morris, P., & Killer, G. (2017). Posttraumatic Stress Disorder, Antipsychotic Use and Risk of Dementia in Veterans. Journal of the American Geriatrics Society, 65(7), 1521-1526.
DOI Scopus20 WoS20 Europe PMC17
2017 Pratt, N. L., Kalisch Ellett, L. M., Sluggett, J. K., Gadzhanova, S. V., Ramsay, E. N., Kerr, M., . . . Roughead, E. E. (2017). Use of proton pump inhibitors among older Australians: National quality improvement programmes have led to sustained practice change. International Journal for Quality in Health Care, 29(1), 75-82.
DOI Scopus27 WoS21 Europe PMC22
2017 Bartlett, L. E., Pratt, N., & Roughead, E. E. (2017). Does tablet formulation alone improve adherence and persistence: a comparison of ezetimibe fixed dose combination versus ezetimibe separate pill combination?. British Journal of Clinical Pharmacology, 83(1), 202-210.
DOI Scopus18 WoS17 Europe PMC17
2016 Inacio, M. C. S., Pratt, N. L., Roughead, E. E., & Graves, S. E. (2016). Response to Letter to the Editor: 'use of preoperative comorbidity scores to predict mortality after total arthroplasty'. Osteoarthritis and cartilage, 25(1), e7.
DOI
2016 Namba, R. S., Inacio, M. C. S., Pratt, N. L., Graves, S. E., Roughead, E. E., Craig Cheetham, T., & Paxton, E. W. (2016). Postoperative opioid use as an early indication of total hip arthroplasty failure. Acta Orthopaedica, 87(eSuppl 362), 37-43.
DOI Scopus42 WoS35 Europe PMC33
2016 Kalisch Ellett, L. M., Pratt, N. L., Le, B. V. T., Westaway, K., & Roughead, E. E. (2016). Increased risk of hospital admission for dehydration or heat-related illness after initiation of medicines: a sequence symmetry analysis. Journal of clinical pharmacy and therapeutics, 41(5), 503-507.
DOI Scopus34 WoS25 Europe PMC26
2016 Wahab, I. A., Pratt, N. L., Ellett, L. K., & Roughead, E. E. (2016). Sequence symmetry analysis as a signal detection tool for potential heart failure adverse events in an administrative claims database. Drug Safety, 39(4), 347-354.
DOI Scopus20 WoS19 Europe PMC15
2016 Shin, J. Y., Roughead, E. E., Park, B. J., & Pratt, N. L. (2016). Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study. BMJ, 353(i2550), i2550-1-i2550-8.
DOI Scopus107 WoS94 Europe PMC75
2016 Inacio, M. C. S., Pratt, N. L., Roughead, E. E., & Graves, S. E. (2016). Evaluation of three co-morbidity measures to predict mortality in patients undergoing total joint arthroplasty. Osteoarthritis and Cartilage, 24(10), 1718-1726.
DOI Scopus32 WoS24 Europe PMC23
2016 Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Sluggett, J. K., Barratt, J. D., & Roughead, E. E. (2016). Central Nervous System-Acting Medicines and Risk of Hospital Admission for Confusion, Delirium, or Dementia. Journal of the American Medical Directors Association, 17(6), 530-534.
DOI Scopus9 WoS9 Europe PMC7
2016 Inacio, M. C. S., Pratt, N. L., Roughead, E. E., Paxton, E. W., & Graves, S. E. (2016). Opioid use after total hip arthroplasty surgery is associated with revision surgery. BMC Musculoskeletal Disorders, 17(1), 122-1-122-9.
DOI Scopus48 WoS43 Europe PMC43
2016 Widagdo, I. S., Pratt, N., Russell, M., & Roughead, E. E. (2016). Construct validity of four frailty measures in an older Australian population: a Rasch analysis. Journal of frailty & aging, 5(2), 78-81.
DOI Scopus17 WoS16 Europe PMC16
2016 Pratt, N., Ramsay, E., Caughey, G., Shakib, S., & Roughead, E. (2016). Uptake of novel oral anticoagulants in Australia. Medical Journal of Australia, 204(3), 104-105.
DOI Scopus30 WoS26 Europe PMC21
2016 Caughey, G., Vitry, A., Ramsay, E., Gilbert, A., Shakib, S., Ryan, P., . . . Roughead, E. (2016). Effect of a general practitioner management plan on health outcomes and hospitalisations in older patients with diabetes. Internal Medicine Journal, 46(12), 1430-1436.
DOI Scopus13 WoS15 Europe PMC11
2016 Roughead, E. E., Chan, E. W., Choi, N. K., Griffiths, J., Jin, X. M., Lee, J., . . . Pratt, N. L. (2016). Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis. Expert Opinion on Drug Safety, 15(12), 1589-1595.
DOI Scopus36 WoS33 Europe PMC32
2016 Inacio, M., Hansen, C., Pratt, N., Graves, S., & Roughead, E. (2016). Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: a retrospective cohort study. BMJ Open, 6(4), e010664-1-e010664-10.
DOI Scopus177 WoS165 Europe PMC149
2016 Hoang, T., Liu, J., Pratt, N., Zheng, V. W., Chang, K. C., Roughead, E., & Li, J. (2016). Detecting signals of detrimental prescribing cascades from social media. Artificial Intelligence in Medicine, 71, 43-56.
DOI Scopus15 WoS13 Europe PMC8
2016 Gadzhanova, S., & Roughead, E. (2016). Prescribed antibiotic use in Australian children aged 0-12 years. Australian family physician, 45(3), 134-138.
Scopus12 WoS9 Europe PMC10
2016 Gadzhanova, S., Roughead, E. E., & Bartlett, L. E. (2016). Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia. European Journal of Clinical Pharmacology, 72(6), 1-7.
DOI Scopus7 WoS7 Europe PMC7
2016 Shin, H. Y., Gadzhanova, S., Roughead, E. E., Ward, M. B., & Pont, L. G. (2016). The use of antipsychotics among people treated with medications for dementia in residential aged care facilities. International Psychogeriatrics, 28(6), 977-982.
DOI Scopus12 WoS13 Europe PMC12
2016 Roughead, E. E., Semple, S. J., & Rosenfeld, E. (2016). The extent of medication errors and adverse drug reactions throughout the patient journey in acute care in Australia. International journal of evidence-based healthcare, 14(3), 113-122.
DOI Europe PMC82
2016 Kjosavik, S. R., Gillam, M. H., & Roughead, E. E. (2016). Average duration of treatment with antidepressants among concession card holders in Australia. Australian & New Zealand Journal of Psychiatry, 50(12), 1180-1185.
DOI Scopus12 WoS12 Europe PMC9
2016 Kemp, C. A., Roughead, E. E., Saunders, C., Boyle, F., Lopez, D., Bulsara, M., & Preen, D. B. (2016). Breast cancer recurrence following active treatment: determining its incidence in the NSW population. Public health research and practice, 26(1, article no. e2611607), 1-8.
DOI Europe PMC5
2016 Westaway, K., Sluggett, J. K., Alderman, C., Procter, N., & Roughead, E. (2016). Prevalence of multiple antipsychotic use and associated adverse effects in Australians with mental illness. International journal of evidence-based healthcare, 14(3), 104-112.
DOI Scopus18 WoS18 Europe PMC14
2015 Roughead, E. E. (2015). Multidrug interactions: the current clinical and pharmacovigilance challenge. Journal of Pharmacy Practice and Research, 45(2), 138-139.
DOI
2015 Hill, S. R., Bero, L., McColl, G., & Roughead, E. E. (2015). Expensive medicines: Ensuring objective appraisal and equitable access. Bulletin of the World Health Organization, 93(1), 4.
DOI
2015 Vitry, A., Nguyen, T., Entwistle, V., & Roughead, E. (2015). Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study. Journal of Pharmaceutical Policy and Practice, 8(25), 1-11.
DOI Scopus44 Europe PMC26
2015 Roughead, E. E. (2015). Data informs debate. Australian prescriber, 38(2), 38-39.
DOI
2015 Othman, N., Vitry, A. I., Roughead, E. E., Ismail, S. B., & Omar, K. (2015). Doctors' views on the quality of claims provided by pharmaceutical representatives: a comparative study in Malaysia and Australia. Journal of Taibah University Medical Sciences, 10(4), 471-480.
DOI Scopus4 WoS4
2015 Gadzhanova, S., Roughead, E. E., & Pont, L. G. (2015). Safety of opioid patch initiation in Australian residential aged care. Medical Journal of Australia, 203(7), 298.e1-298.e6.
DOI Scopus14 WoS12 Europe PMC11
2015 Gadzhanova, S., & Roughead, E. (2015). Use of prescription medicines in Australian women of child-bearing age. BMC Pharmacology and Toxicology, 16(1), 1-12.
DOI Scopus7 WoS6 Europe PMC6
2015 Gadzhanova, S., Roughead, E., & Robinson, M. (2015). Use of medicines with anticholinergic and sedative effect before and after initiation of anti-dementia medications. Drugs, 2(1), 53-60.
DOI Scopus15 Europe PMC13
2015 Gadzhanova, S., & Roughead, E. (2015). Survival after initiation of androgen deprivation therapy for prostate cancer of Australian men. Cancer Epidemiology, 39(6), 854-859.
DOI Scopus2 WoS1
2015 Ellett, L. M. K., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2015). Re: Multiple Anticholinergic Medication Use and Risk of Hospital Admission for Confusion or Dementia Editorial Comment. JOURNAL OF UROLOGY, 194(5), 1353.
DOI
2015 Poh, E. W., McArthur, A., & Roughead, L. (2015). The effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review protocol.. JBI database of systematic reviews and implementation reports, 13(12), 4-13.
DOI Scopus1 Europe PMC1
2015 Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., . . . Martin, J. H. (2015). Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Internal Medicine, 175(5), 827-834.
DOI WoS1084 Europe PMC950
2015 Inacio, M. C. S., Pratt, N. L., Roughead, E. E., & Graves, S. E. (2015). Predicting infections after total joint arthroplasty using a prescription based comorbidity measure. The Journal of Arthroplasty, 30(10), 1692-1698.
DOI Scopus19 WoS14 Europe PMC16
2015 Lai, E. C. C., Man, K. K. C., Chaiyakunapruk, N., Cheng, C. L., Pratt, N., Roughead, L., & Setoguchi, S. (2015). Databases in the Asia-Pacific region: the potential for a distributed network approach. Epidemiology, 26(6), 815-820.
DOI Scopus55 WoS51 Europe PMC37
2015 Nguyen, T., Caughey, G., Pratt, N., Shakib, S., Kemp, A., & Roughead, E. (2015). Hospitalization for drug-induced hepatotoxicity: linking Y-codes with pharmaceutical claims data to identify implicated medicines. Journal of Clinical Pharmacy and Therapeutics, 40(2), 213-219.
DOI Scopus2 WoS2 Europe PMC2
2015 Inacio, M. C. S., Pratt, N. L., Roughead, E. E., & Graves, S. E. (2015). Comparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson Measures: a cross-sectional evaluation. BMC Musculoskeletal Disorders, 16(1), 385-1-385-9.
DOI Scopus27 WoS24 Europe PMC20
2015 Widagdo, I. S., Pratt, N., Russell, M., & Roughead, E. E. (2015). Predictive performance of four frailty measures in an older Australian population. Age and Ageing, 44(6), 967-972.
DOI Scopus35 WoS36 Europe PMC31
2015 Inacio, M. C. S., Pratt, N. L., Roughead, E. E., & Graves, S. E. (2015). Using medications for prediction of revision after total joint arthroplasty. Journal of Arthroplasty, 30(12), 2061-2070.
DOI Scopus11 WoS10 Europe PMC9
2015 Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2015). Response to lertxundi and colleagues. Journal of the American geriatrics society, 63(5), 1054-1055.
DOI
2015 Pratt, N., Chan, E. W., Choi, N. K., Kimura, M., Kimura, T., Kubota, K., . . . Roughead, E. E. (2015). Prescription sequence symmetry analysis: assessing risk, temporality, and consistency for adverse drug reactions across datasets in five countries. Pharmacoepidemiology and Drug Safety, 24(8), 858-864.
DOI Scopus53 WoS48 Europe PMC38
2015 Widagdo, I., Pratt, N., Russell, M., & Roughead, E. (2015). How common is frailty in older Australians?. Australasian Journal on Ageing, 34(4), 247-251.
DOI Scopus16 WoS13 Europe PMC11
2015 Leach, M. J., Pratt, N. L., & Roughead, E. E. (2015). Psychoactive medicine use and the risk of hip fracture in older people: a case-crossover study. Pharmacoepidemiology and Drug Safety, 24(6), 576-582.
DOI Scopus17 WoS15 Europe PMC14
2015 Pratt, N. L., Kalisch Ellett, L. M., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2015). Commitment questions targeting patients promotes uptake of under-used health services: findings from a national quality improvement program in Australia. Social Science and Medicine, 145, 1-6.
DOI Scopus6 WoS6 Europe PMC6
2015 Roughead, E. E., Chan, E. W., Choi, N. K., Kimura, M., Kimura, T., Kubota, K., . . . Pratt, N. L. (2015). Variation in association between thiazolidinediones and heart failure across ethnic groups: retrospective analysis of large healthcare claims databases in six countries. Drug Safety, 38(9), 823-831.
DOI Scopus38 WoS35 Europe PMC29
2015 Pratt, N. L., Ramsay, E. N., Kalisch Ellett, L. M., Nguyen, T. A., & Roughead, E. E. (2015). Association between ophthalmic timolol and hospitalisation for bradycardia. Journal of ophthalmology, 2015(article no. 567387), 1-6.
DOI Scopus18 WoS14 Europe PMC11
2015 Caughey, G., Kalisch Ellett, L., Goldstein, S., & Roughead, E. (2015). Suboptimal medication-related quality of care preceding hospitalisation of older patients. Medical Journal of Australia, 203(5), 220.e1-220.e7.
DOI Scopus6 WoS6 Europe PMC6
2015 Roughead, E. E., & Pratt, N. L. (2015). Impact on drug safety of variation in adherence: the need for routinely reporting measures of dose Intensity in medication safety studies using electronic health data. Drug Safety, 38(12), 1145-1152.
DOI Scopus2 WoS2 Europe PMC1
2014 Kalisch Ellett, L. M., Pratt, N. L., Ramsay, E. N., Barratt, J. D., & Roughead, E. E. (2014). Multiple anticholinergic medication use and risk of hospital admission for confusion or dementia. Journal of the American Geriatric Society, 62(10), 1916-1922.
DOI Scopus105 WoS88 Europe PMC77
2014 Pratt, N. L., Ramsay, E. N., Kalisch Ellett, L. M., Nguyen, T. A., Barratt, J. D., & Roughead, E. E. (2014). Association between use of multiple psychoactive medicines and hospitalization for falls : retrospective analysis of a large healthcare claim database. Drug safety, 37(7), 529-535.
DOI Scopus35 WoS33 Europe PMC28
2014 Pratt, N. L., Ilomäki, J., Raymond, C., & Roughead, E. E. (2014). The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines : a simulation study. BMC medical research methodology, 14(article no. 66), 9 pages.
DOI Scopus37 WoS32 Europe PMC27
2014 Kalisch Ellett, L. M., Pratt, N. L., Barratt, J. D., Rowett, D., & Roughead, E. E. (2014). Risk of medication-associated initiation of oxybutynin in elderly men and women. Journal of the American Geriatrics Society, 62(4), 690-695.
DOI Scopus22 WoS20 Europe PMC16
2014 Wahab, I. A., Pratt, N. L., Kalisch, L. M., & Roughead, E. E. (2014). Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database : a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in Australia. Drug safety, 37(1), 53-64.
DOI Scopus33 WoS32 Europe PMC24
2014 Pratt, N., Graves, S., Cashman, K., Caughey, G., & Roughead, E. (2014). Anti-Coagulation After Hip or Knee Joint Replacement: Assessment of the Benefits and Risks in an Elderly Cohort. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 23, 485-486.
2014 Lai, E. C. C., Chaiyakunapruk, N., Zhang, Y., Hardy, C., Kubota, K., Roughead, E. E., . . . Setoguchi, S. (2014). Databases in Asia: the potential for distributed network approach. Pharmacoepidemiology and drug safety, 23(s1, article no. 689), 369-370.
2014 Nguyen, T. A., Knight, R., Roughead, E. E., Brooks, G., & Mant, A. (2014). Policy options for pharmaceutical pricing and purchasing: issues for low- and middle-income countries. Health policy and planning, 30(2), 267-280.
DOI Scopus85 Europe PMC55
2014 Pratt, N., Ramsay, E., Kemp, A., Kalisch-Ellett, L., Shakib, S., Caughey, G., . . . Roughead, E. (2014). Ranibizumab and risk of hospitalisation for ischaemic stroke and myocardial infarction in patients with age-related macular degeneration: a self-controlled case-series analysis. Drug Safety, 37(12), 1021-1027.
DOI Scopus17 WoS13 Europe PMC14
2014 Vitry, A., Nguyen, T., Ramsay, E., Caughey, G., Gilbert, A., Shakib, S., . . . Roughead, E. (2014). General practitioner management plans delaying time to next potentially preventable hospitalisation for patients with heart failure. Internal Medicine Journal, 44(11), 1117-1123.
DOI Scopus17 WoS14 Europe PMC17
2014 Kemp, A., Preen, D. B., Saunders, C., Boyle, F., Bulsara, M., Holman, C. D. J., . . . Roughead, E. E. (2014). Women commencing anastrozole, letrozole or tamoxifen for early breast cancer: the impact of comorbidity and demographics on initial choice. PLoS one, 9(1, article no. e84835), 1-8.
DOI Europe PMC7
2014 Kemp, A., Preen, D. B., Saunders, C., Boyle, F., Bulsara, M., Malacova, E., & Roughead, E. E. (2014). Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?. SpringerPlus, 3(282), 1-10.
DOI Europe PMC36
2014 Gadzhanova, S., Roughead, E., & Ilomaki, J. (2014). Use of statins in an Australian elderly population. International journal of clinical cardiology, 1(3, article no. 016), 1-4.
2014 Vitry, A., & Roughead, E. (2014). Managed entry agreements for pharmaceuticals in Australia. Health policy, 117(3), 345-352.
DOI Europe PMC31
2014 Gadzhanova, S., & Roughead, E. (2014). Co-prescribing of warfarin with statins and Proton Pump Inhibitors in elderly Australians. Advances in pharmacoepidemiology & drug safety, 3(3), 1-4.
DOI
2014 Leach, M. J., Pratt, N. L., & Roughead, E. E. (2014). Medicine use among the elderly before and after hip fracture. The Australian journal of pharmacy, 95(1125), 72-74.
2013 Kemp, A., Preen, D., Saunders, C., Holman, D., Bulsara, M., Rogers, K., & Roughead, E. E. (2013). Ascertaining invasive breast cancer cases : the validity of administrative and self-reported data sources in Australia. BMC medical research methodology, 13(17), 1-8.
DOI
2013 Roughead, E. E., Lhazeen, K., Socialine, E., Bahri, S., Park, B. J., & Holloway, K. (2013). Monitoring medicines use to support national medicines policy development and implementation in the Asia Pacific region. WHO South-East Asia journal of public health, 2(2), 113-117.
DOI Europe PMC8
2013 Wahab, I. A., Pratt, N. L., Kalisch Ellett, L. M., & Roughead, E. E. (2013). Sequence symmetry analysis and disproportionality analyses: what percentage of adverse drug reaction do they signal?. Advances in pharmacoepidemiology & drug safety, 2(4), 1-5.
DOI
2013 Pratt, N., Andersen, M., Bergman, U., Choi, N. K., Gerhard, T., Huang, C., . . . Roughead, E. E. (2013). Multi-country rapid adverse drug event assessment: the Asian Pharmacoepidemiology Network (AsPEN) antipsychotic and acute hyperglycaemia study. Pharmacoepidemiology and Drug Safety, 22(9), 915-924.
DOI Scopus52 WoS47 Europe PMC43
2013 Anderson, M., Bergman, U., Choi, N. K., Gerhard, T., Huang, C., Jalbert, J., . . . Yang, Y. H. K. (2013). The Asian Pharmacoepidemiology Network (AsPEN) : promoting multi-national collaboration for pharmacoepidemiologic research in Asia. Pharmacoepidemiology and drug safety, 22(7), 700-704.
DOI Scopus66 WoS55 Europe PMC49
2013 Roughead, E., Kalisch Ellett, L., Ramsay, E., Pratt, N., Barratt, J., LeBlanc, V., . . . Gilbert, A. (2013). Bridging evidence-practice gaps: improving use of medicines in elderly Australian veterans. BMC Health Services Research, 13(article no. 514), 1-14.
DOI Scopus29 WoS28 Europe PMC25
2013 Ramsay, E., Pratt, N., Ryan, P., & Roughead, E. (2013). Proton pump inhibitors and the risk of pneumonia: A comparison of cohort and self-controlled case series designs. BMC Medical Research Methodology, 13(1), 1-7.
DOI Scopus24 WoS23 Europe PMC21
2013 Caughey, G., Preiss, A., Vitry, A., Gilbert, A., Ryan, P., Shakib, S., . . . Roughead, E. (2013). Does antidepressant medication use affect persistence with diabetes medicines?. Pharmacoepidemiology and Drug Safety, 22(6), 615-622.
DOI Scopus16 WoS15 Europe PMC13
2013 Kemp, A., Preen, D., Glover, J., Semmens, J., & Roughead, E. (2013). Impact of cost of medicines for chronic conditions on low income households in Australia. Journal of Health Services Research & Policy, 18(1), 21-27.
DOI Scopus20 WoS22 Europe PMC16
2013 Kemp, A., Glover, J., Preen, D., Bulsara, M., Semmens, J., & Roughead, E. (2013). From the city to the bush: Increases in patient co-payments for medicines have impacted on medicine use across Australia. Australian Health Review, 37(1), 4-10.
DOI Scopus10 WoS11 Europe PMC6
2013 Wahab, I. A., Pratt, N. L., Wiese, M. D., Kalisch, L. M., & Roughead, E. E. (2013). The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiology and drug safety, 22(5), 496-502.
DOI Scopus69 WoS62 Europe PMC59
2013 Caughey, G. E., Preiss, A. K., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2013). Comorbid diabetes and copd: impact of corticosteroid use on diabetes complications. Diabetes Care, 36(10), 3009-3014.
DOI Scopus55 WoS51 Europe PMC47
2013 Sluggett, J. K., Caughey, G. E., Ward, M. B., Roughead, E. E., & Gilbert, A. L. (2013). Transient ischaemic attack and ischaemic stroke : constructing episodes of care using hospital claims data. BMC research notes, 6(128), 1-6.
DOI Scopus8 Europe PMC7
2013 Kalisch Ellett, L. M., Pratt, N. L., Barratt, J. D., & Roughead, E. E. (2013). Urinary incontinence: a poorly recognised adverse effect of medicines. Pharmacoepidemiology and drug safety, 22(s1, article no. 948), 475.
2013 Pratt, N., Ilomaki, J., Raymond, C., & Roughead, E. (2013). Validation of the adjusted sequence ratio in prescription sequence symmetry analysis: a simulation study. Pharmacoepidemiology and drug safety, 22(s1, article no. 464), 228-229.
2013 Wang, T., Pratt, N., Killer, G., Roughead, E. E., & Griffiths, J. (2013). Proton pump inhibitors and clostridium difficile-associated disease in Canadian and Australian community settings - a prescription sequence symmetry analysis. Pharmacoepidemiology and drug safety, 22(s1, article no. 384), 187-188.
2013 Leach, M. J., Pratt, N. L., & Roughead, E. E. (2013). Medicine use among older Australians before and after hip fracture. Journal of pharmacy practice and research, 43(4), 265-268.
DOI Scopus6
2013 Wahab, I. A., Pratt, N. L., Kalisch Ellett, L. M., & Roughead, E. E. (2013). The detection of adverse events in randomized clinical trials : can we really say new medicines are safe?. Current drug safety, 8(2), 104-113.
DOI Scopus13 WoS13 Europe PMC11
2013 Gadzhanova, S., Bell, J. S., & Roughead, E. E. (2013). What analgesics do older people use prior to initiating oxycodone for non-cancer pain?: a retrospective database study. Drugs & aging, 30(11), 921-926.
DOI Scopus16 WoS16 Europe PMC15
2013 Gadzhanova, S., Ilomäki, J., & Roughead, E. E. (2013). Antihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective study. International journal of clinical pharmacy, 35(4), 613-620.
DOI Scopus7 WoS7 Europe PMC5
2013 Gadzhanova, S. V., Roughead, E. E., & Bartlett, M. J. (2013). Improving cardiovascular disease management in Australia : NPS MedicineWise. Medical journal of Australia, 199(3), 192-195.
DOI Scopus11 WoS11 Europe PMC9
2013 Kalisch Ellett, L. M., Ramsay, E. N., Barratt, J. D., Gilbert, A. L., & Roughead, E. E. (2013). Home medicines reviews: extent of uptake by high-risk veterans. Journal of pharmacy practice and research, 43(3), 182-186.
DOI Scopus9
2012 Gadzhanova, S., Ilomaki, J., & Roughead, E. E. (2012). COX-2 inhibitor and non-selective NSAID use in those at increased risk of NSAID-related adverse events: a retrospective database study. Drugs & aging, 30(1), 23-30.
DOI Scopus9 WoS8 Europe PMC6
2012 Roughead, E. E., Kalisch Ellett, L. M., Pratt, N. L., Killer, G., Barnard, A., & Gilbert, A. L. (2012). Managing glaucoma in those with co-morbidity : not as easy as it seems. Ophthalmic Epidemiology, 19(2), 74-82.
DOI Scopus33 WoS26 Europe PMC22
2012 Vitry, A., Roughead, E., Ramsay, E., Ryan, P., Caughey, G., Esterman, A., . . . McDermott, R. (2012). Chronic disease management: Does the disease affect likelihood of care planning?. Australian Health Review, 36(4), 419-423.
DOI Scopus9 WoS10 Europe PMC7
2012 Pratt, N., Roughead, E., Salter, A., & Ryan, P. (2012). Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review. BMC Medical Research Methodology, 12(1), 1-19.
DOI Scopus43 WoS39 Europe PMC32
2012 Kalisch, L., Caughey, G., Barratt, J., Ramsay, E., Killer, G., Gilbert, A., & Roughead, E. (2012). Prevalence of preventable medication-related hospitalizations in Australia: An opportunity to reduce harm. International Journal for Quality in Health Care, 24(3), 239-249.
DOI Scopus63 WoS53 Europe PMC47
2012 Kemp, A., Glover, J., Preen, D. B., Bulsara, M., Semmens, J., & Roughead, E. E. (2012). Have Increases in Co-Payments for Medicines Further Burdened Australians in Remote and Disadvantaged Areas?. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 21, 294-295.
2012 Lu, C., & Roughead, E. E. (2012). New users of antidepressant medications: first episode duration and predictors of discontinuation. European journal of clinical pharmacology, 68(1), 65-71.
DOI Scopus36 Europe PMC29
2012 Clark, A., & Roughead, L. (2012). Pharmacists perspective on managing older patients with multiple chronic conditions. Australian pharmacist, 31(2), 148-150.
2012 Ostini, R., Roughead, E. E., Kirkpatrick, C. M. J., Monteith, G. R., & Tett, S. E. (2012). Quality use of medicines: medication safety issues in naming; look-alike, sound-alike medicine names. International journal of pharmacy practice, 20(6), 349-357.
DOI
2011 Lu, C. Y., & Roughead, E. (2011). Determinants of patient-reported medication errors : a comparison among seven countries. International journal of clinical practice, 65(7), 733-740.
DOI Scopus35 WoS30 Europe PMC22
2011 Chanjaruporn, F., Roughead, E. E., Sooksriwong, C. O., & Kaojarem, S. (2011). Budget impact analysis of pemetrexed introduction : case study from a teaching hospital perspective, Thailand. Journal of the medical association of Thailand, 94(9), 1026-1034.
2011 Gadzhanova, S. V., Gillies, M., Roughead, E. E., & Zuo, Y. (2011). Fixed dose combination diabetes medicines: usage in the Australian veteran population. Australian Family Physician, 40(10), 811-815.
Scopus5 WoS4 Europe PMC4
2011 Bell, J. S., Kalisch Ellett, L. M., Ramsay, E. N., Pratt, N. L., Barratt, J. D., Le, B. T., . . . Gilbert, A. L. (2011). Prescriber feedback to improve quality use of medicines among older people: the veterans' MATES program. Journal of pharmacy practice and research, 41(4), 316-319.
DOI Scopus13
2011 Roughead, E. E., Vitry, A. I., Caughey, G. E., & Gilbert, A. L. (2011). Multimorbidity, care complexity and prescribing for the elderly. Aging health, 7(5), 695-705.
DOI Scopus47
2011 Vitry, A., Roughead, E., Ramsay, E., Preiss, A., Ryan, P., Gilbert, A., . . . McDermott, R. (2011). Major bleeding risk associated with warfarin and co-medications in the elderly population. Pharmacoepidemiology and Drug Safety, 20(10), 1057-1063.
DOI Scopus52 WoS45 Europe PMC40
2011 Kemp, A., Preen, D., Sanfilippo, F., Glover, J., Semmens, J., & Roughead, E. (2011). Evaluating pharmaceutical policy impacts using interrupted time series analysis: An Australian case study. International Public Health Journal, 3(2), 229-241.
2011 Gilbert, A., Caughey, G., Vitry, A., Clark, A., Ryan, P., McDermott, R., . . . Roughead, E. (2011). Ageing well: Improving the management of patients with multiple chronic health problems. Australasian Journal on Ageing, 30(Suppl 2), 32-37.
DOI Scopus17 WoS18 Europe PMC15
2011 Kemp, A., Preen, D., Glover, J., Semmens, J., & Roughead, E. (2011). How much do we spend on prescription medicines? Out-of-pocket costs for patients in Australia and other OECD countries. Australian Health Review, 35(3), 341-349.
DOI Scopus20 WoS21 Europe PMC18
2011 Ramsay, E., Roughead, E., Ewald, B., Pratt, N., & Ryan, P. (2011). A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly. BMC Medical Research Methodology, 11(106), 106-1-106-7.
DOI Scopus7 WoS7 Europe PMC6
2011 Pratt, N., Roughead, E., Ramsay, E., Salter, A., & Ryan, P. (2011). Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly: A self-controlled case-series analysis in an Australian health care claims database. Drug Safety, 34(7), 567-575.
DOI Scopus72 WoS65 Europe PMC59
2011 Zhang, Y., Vitry, A., Caughey, G., Roughead, E., Ryan, P., Gilbert, A., . . . McDermott, R. (2011). The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes. Diabetes Research and Clinical Practice, 91(1), 115-120.
DOI Scopus5 WoS4 Europe PMC4
2011 Roughead, E., Barratt, J., Ramsay, E., Pratt, N., Ryan, P., Peck, R., . . . Gilbert, A. (2011). Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans. Journal of Clinical Pharmacy and Therapeutics, 36(1), 27-32.
DOI Scopus52 WoS39 Europe PMC31
2011 Caughey, G., Roughead, E., Shakib, S., Vitry, A., & Gilbert, A. (2011). Co-morbidity and potential treatment conflicts in elderly heart failure patients: A retrospective, cross-sectional study of administrative claims data. Drugs and Aging, 28(7), 575-581.
DOI Scopus36 WoS25 Europe PMC31
2011 Roughead, E., Kalisch, L., Ramsay, E., Ryan, P., & Gilbert, A. (2011). Continuity of care: when do patients visit community health care providers after leaving hospital?. Internal Medicine Journal, 41(9), 662-667.
DOI Scopus37 WoS38 Europe PMC29
2011 Caughey, G. E., & Roughead, E. E. (2011). Multimorbidity research challenges: where to go from here?. Journal of comorbidity, 1(1), 8-10.
DOI Europe PMC18
2011 Kalisch Ellett, L. M., Caughey, G. E., Roughead, E. E., & Gilbert, A. L. (2011). The prescribing cascade. Australian prescriber, 34(6), 162-166.
DOI Scopus80 WoS60
2011 Caughey, G. E., Roughead, E. E., Pratt, N. L., Killer, G., & Gilbert, A. L. (2011). Stroke risk and NSAIDs: an Australian population-based study. Medical journal of Australia, 195(9), 525-529.
DOI Scopus53 WoS39 Europe PMC30
2011 Gadzhanova, S., Roughead, E. E., Loukas, K., & Vajda, J. (2011). Improvement in metformin and insulin utilisation in the Australian veteran population associated with quality use of medicines intervention programs. Pharmacoepidemiology and drug safety, 20(4), 359-365.
DOI Scopus4 WoS4 Europe PMC3
2011 Gadzhanova, S. V., Roughead, E. E., & Mackson, J. M. (2011). Initiation and duration of proton pump inhibitors in the Australian veteran population. Internal medicine journal, 42(5), e68-e73.
DOI Scopus14 WoS11 Europe PMC13
2011 Woodward, M. C., Roughead, E. E., Kalisch, L. M., Pratt, N. L., & Le, B. V. T. (2011). Urinary incontinence - are medicines contributing to the problem?. Australasian journal on ageing, 30(1), 28.
DOI
2011 Lu, C. Y., Barratt, J., Vitry, A., & Roughead, E. (2011). Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. Journal of clinical epidemiology, 64(2), 223-228.
DOI Scopus88 Europe PMC76
2010 Roughead, E. E., Kalisch Ellett, L. M., Barratt, J. D., & Gilbert, A. L. (2010). Prevalence of potentially hazardous drug interactions amongst Australian veterans. British journal of clinical pharmacology, 70(2), 252-257.
DOI Scopus57 WoS43 Europe PMC38
2010 Kalisch, L. M., Roughead, E. E., & Gilbert, A. L. (2010). Improving heart failure outcomes with pharmacist-physician collaboration: How close are we?. Future Cardiology, 6(2), 255-268.
DOI Scopus10 WoS8 Europe PMC6
2010 Gadzhanova, S. V., Roughead, E. E., & Mackson, J. (2010). Anticholinesterase duration in the Australian veteran population. Australian and New Zealand journal of psychiatry, 44(5), 469-474.
DOI Scopus11 WoS11 Europe PMC10
2010 Roughead, E., Vitry, A., Preiss, A., Barratt, J., Gilbert, A., & Ryan, P. (2010). Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease. European Journal of Cardiovascular Prevention ' Rehabilitation, 17(1), 71-76.
DOI Scopus13 WoS13 Europe PMC11
2010 Caughey, G., Roughead, E., Vitry, A., McDermott, R., Shakib, S., & Gilbert, A. (2010). Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Research and Clinical Practice, 87(3), 385-393.
DOI Scopus161 WoS144 Europe PMC132
2010 Caughey, G., Ramsay, E., Vitry, A., Gilbert, A., Luszcz, M., Ryan, P., & Roughead, E. (2010). Comorbid chronic diseases, discordant impact on mortality in older people: a 14-year longitudinal population study. Journal of Epidemiology and Community Health, 64(12), 1036-1042.
DOI Scopus77 WoS66 Europe PMC69
2010 Caughey, G., Roughead, E., Shakib, S., McDermott, R., Vitry, A., & Gilbert, A. (2010). Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age and Ageing, 39(4), 488-494.
DOI Scopus47 WoS41 Europe PMC35
2010 Pratt, N., Roughead, E., Salter, A., & Ryan, P. (2010). Factors associated with choice of antipsychotic treatment in elderly veterans: potential confounders for observational studies. Australian and New Zealand Journal of Public Health, 34(6), 589-593.
DOI Scopus5 WoS5 Europe PMC4
2010 Pratt, N., Roughead, E., Ramsay, E., Salter, A., & Ryan, P. (2010). Risk of hospitalization for stroke associated with antipsychotic use in the elderly: A self-controlled case series. Drugs & Aging, 27(11), 885-893.
DOI Scopus34 WoS32 Europe PMC30
2010 Vitry, A., Roughead, E., Preiss, A., Ryan, P., Ramsay, E., Gilbert, A., . . . McDermott, R. (2010). Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort study. PLoS One, 5(11), 1-5.
DOI Scopus34 WoS32 Europe PMC27
2010 Caughey, G., Roughead, E., Pratt, N., Shakib, S., Vitry, A., & Gilbert, A. (2010). Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?. Pharmacoepidemiology and Drug Safety, 19(9), 977-982.
DOI Scopus62 WoS57 Europe PMC46
2010 Pratt, N., Roughead, E., Ryan, P., & Salter, A. (2010). Antipsychotics and the risk of death in the elderly: an instrumental variable analysis using two preference based instruments. Pharmacoepidemiology and Drug Safety, 19(7), 699-707.
DOI Scopus30 WoS28 Europe PMC28
2010 Zhang, Y., Chow, V., Vitry, A., Ryan, P., Roughead, E., Caughey, G., . . . Luszcz, M. (2010). Antidepressant use and depressive symptomatology among older people from the Australian Longitudinal Study of Ageing. International Psychogeriatrics, 22(3), 437-444.
DOI Scopus22 WoS22 Europe PMC21
2010 Pratt, N., Roughead, E., Ryan, P., & Gilbert, A. (2010). Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: A retrospective cohort study. Drugs & Aging, 27(1), 63-71.
DOI Scopus23 WoS18 Europe PMC17
2010 Zhang, Y., Vitry, A., Roughead, E., Ryan, P., & Gilbert, A. (2010). Co-morbidity and the utilization of health care for Australian veterans with diabetes. Diabetic Medicine, 27(1), 65-71.
DOI Scopus15 WoS10 Europe PMC7
2010 Kemp, A., Roughead, E., Preen, D., Glover, J., & Semmens, J. (2010). Determinants of self-reported medicine underuse due to cost: A comparison of seven countries. Journal of Health Services Research & Policy, 15(2), 106-114.
DOI Scopus70 WoS66 Europe PMC45
2010 Roughead, E., Kalisch, L., Ramsay, E., Ryan, P., & Gilbert, A. (2010). Use of health services and medicines amongst Australian war veterans: a comparison of young elderly, near centenarians and centenarians. BMC Geriatrics, 10(1), 83-90.
DOI Scopus13 WoS9 Europe PMC8
2010 Vitry, A. I., Roughead, E. E., Ramsay, E. N., Preiss, A. K., Caughey, G. E., Gilbert, A. L., & Ryan, P. (2010). Major Bleeding Risk Associated with Warfarin and Co-Medications in the Elderly Population. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 19, S132.
2010 Othman, N., Vitry, A. I., Roughead, E. E., Ismail, S. B., & Omar, K. (2010). Medicines information provided by pharmaceutical representatives: a comparative study in Australia and Malaysia. BMC public health, 10(743), 1-11.
DOI Scopus29 WoS18 Europe PMC22
2010 Othman, N., Vitry, A. I., & Roughead, E. E. (2010). Quality of claims, references and the presentation of risk results in medical journal advertising : a comparative study in Australia, Malaysia and the United States. BMC public health, 10(1), article no. 294.
DOI
2010 Othman, N., Vitry, A. I., & Roughead, E. E. (2010). Medicines information in medical journal advertising in Australia, Malaysia and the United States : a comparative cross-sectional study. Southern Med Review, 3(1), 11-18.
Europe PMC4
2009 Roughead, E. E., & Semple, S. J. (2009). Medication safety in acute care in Australia : where are we now? Part 1 : a review of the extent and causes of medication problems 2002-2008. Australia and New Zealand health policy, 6(no. 1, article no. 18), 1-12.
DOI Europe PMC88
2009 Othman, N., Vitry, A., & Roughead, E. E. (2009). Quality of pharmaceutical advertisements in medical journals : a systematic review. PLoS one, 4(7, article no. e6350), 1-11.
DOI Europe PMC52
2009 Morgan, S., Kennedy, J., Boothe, K., McMahon, M., Watson, D., & Roughead, E. (2009). Toward an understanding of high performance, pharmaceutical policy systems : a "triple-A" framework and example analysis. Open health services and policy journal, 2(1), 1-9.
DOI
2009 Semple, S. J., & Roughead, E. E. (2009). Medication safety in acute care in Australia : where are we now? Part 2 : a review of strategies and activities for improving medication safety 2002-2008. Australia and New Zealand health policy, 6(1), article no. 24.
DOI Europe PMC23
2009 Pratt, N., Roughead, E., Ryan, P., Peck, R., & Gilbert, A. (2009). Antipsychotics and the Risk of Hip Fracture, Pneumonia and Stroke: Self-Controlled Case Series and Instrumental Variable Analysis Results. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 18, S108.
2009 Gilbert, A. L., Roughead, E. E., Barratt, J. D., Ramsey, E., Pratt, N., Ryan, P., . . . Killer, G. (2009). The Effectiveness of Collaborative Medicine Reviews in Delaying Time to Next Hospitalisation for Heart Failure Patients in the Ambulatory Setting: Results of a Cohort Study. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 18, S122.
2009 Roughead, E., Barratt, J., Ramsay, E., Pratt, N., Ryan, P., Peck, R., . . . Gilbert, A. (2009). The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circulation. Heart Failure, 2(5), 424-428.
DOI Scopus121 WoS90 Europe PMC77
2009 Roughead, E., Ramsay, E., Pratt, N., Ryan, P., & Gilbert, A. (2009). Proton-pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia. Medical Journal of Australia, 190(3), 114-116.
DOI Scopus28 WoS23 Europe PMC20
2009 Hynd, A., Roughead, E., Preen, D., Glover, J., Bulsara, M., & Semmens, J. (2009). Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia. Australian and New Zealand Journal of Public Health, 33(3), 246-252.
DOI Scopus24 WoS24 Europe PMC20
2009 Vitry, A., Wong, S., Roughead, E., Ramsay, E., & Barratt, J. (2009). Validity of medication-based co-morbidity indices in the Australian elderly population. Australian and New Zealand Journal of Public Health, 33(2), 126-130.
DOI Scopus94 WoS89 Europe PMC77
2009 Roughead, E., Ramsay, E., Priess, K., Barratt, J., Ryan, P., & Gilbert, A. (2009). Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates. Pharmacoepidemiology and Drug Safety, 18(1), 69-75.
DOI Scopus17 WoS15 Europe PMC15
2009 Kalisch Ellett, L. M., Roughead, E. E., & Gilbert, A. L. (2009). Pharmaceutical brand substitution in Australia : identifying factors associated with having multiple brand substitutions. International journal of pharmacy practice, 17(6), 339-344.
DOI
2008 Kalisch, L. M., Roughead, E. E., & Gilbert, A. L. (2008). Brand substitution or multiple switches per patient? : an analysis of pharmaceutical brand substitution in Australia. Pharmacoepidemiology and drug safety, 17(6), 620-625.
DOI Scopus13 WoS9 Europe PMC6
2008 Hynd, A., Roughead, E., Preen, D., Glover, J., Bulsara, M., & Semmens, J. (2008). The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiology and Drug Safety, 17(11), 1091-1099.
DOI Scopus86 WoS85 Europe PMC68
2008 Roughead, E., Ramsay, E., Pratt, N., & Gilbert, A. (2008). NSAID use in individuals at risk of renal adverse events an observational study to investigate trends in Australian veterans. Drug Safety, 31(11), 997-1003.
DOI Scopus19 WoS16 Europe PMC13
2008 Morgan, S., Kennedy, J., Roughead, L., Boothe, K., McMahon, M., & Watson, D. (2008). Toward high performance 'pharmacare' systems: A review of experiences in seven countries. VALUE IN HEALTH, 11(3), A36.
DOI
2008 Roughead, L., Semmens, J., Preen, D., Hynd, A., & Glover, J. (2008). Rising co-payments comes at a huge cost. Australian Journal of Pharmacy, 89(1064), 44.
2008 Caughey, G. E., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2008). Prevalence of comorbidity of chronic diseases in Australia. BMC public health, 8(1), article no. 221.
DOI Scopus180 WoS155 Europe PMC137
2008 Roughead, E. E., Gilbert, A. L., & Vitry, A. I. (2008). The Australian funding debate on quadrivalent HPV vaccine: a case study for the national pharmaceutical policy. Health Policy, 88(2-3), 250-257.
DOI Europe PMC16
2008 Roughead, E. E., Barratt, J. D., Gilbert, A. L., Peck, R., & Killer, G. (2008). Diabetes processes of care in the Australian veteran population. Diabetes research and clinical practice, 79(2), 299-304.
DOI Europe PMC7
2008 Hughes, C., Roughead, E. E., & Kerse, N. (2008). Improving use of medicines for older people in long-term care: contrasting the policy approach of four countries. Healthcare policy, 3(3), 154-167.
2008 Roughead, E. E., Gilbert, A. L., & Woodward, M. C. (2008). Medication use by Australian war veterans in residential aged-care facilities. Australian journal of hospital pharmacy, 38(1), 14-18.
DOI
2008 Morden, N., Zerzan, J., Rue, T. C., Heagerty, P. J., Roughead, E. E., Soumerai, S., . . . Sullivan, S. (2008). Medicaid prior authorization and controlled-release oxycodone. Medical Care, 46(6), 573-580.
DOI
2008 Roughead, L., Semmens, J., Preen, D., Hynd, A., & Glover, J. (2008). Rising co-payments comes at a huge cost. The Australian Journal of Pharmacy, (1064), 89.
2007 Roughead, E. E., Anderson, B., & Gilbert, A. L. (2007). Potentially inappropriate prescribing among Australian veterans and war widows/widowers. Internal Medicine Journal, 37(6), 402-405.
DOI
2007 Roughead, E. E., Lopert, R., & Sansom, L. N. (2007). International price comparisons for novel and follow-on drugs: a response. Value in Health, 10(6), 512-513.
DOI
2007 Roughead, E. E., Lopert, R., & Sansom, L. N. (2007). Prices for innovative pharmaceutical products that provide health gain : a comparison between Australia and the United States. Value in Health, 10(6), 514-520.
DOI
2007 Roughead, E., Pratt, N., Peck, R., & Gilbert, A. (2007). Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners. Pharmacoepidemiology and Drug Safety, 16(7), 797-803.
DOI Scopus24 WoS23 Europe PMC20
2007 Roughead, E., Pratt, N., & Gilbert, A. (2007). Trends over 5 years in cardiovascular medicine use in Australian veterans with diabetes. British Journal of Clinical Pharmacology, 64(1), 100-104.
DOI Scopus6 WoS6 Europe PMC5
2007 Roughead, E., McDermott, B., & Gilbert, A. (2007). Antidepressants: prevalence of duplicate therapy and avoidable drug interactions in Australian veterans. Australian and New Zealand Journal of Psychiatry, 41(4), 366-370.
DOI
2007 Kalisch, L. M., Roughead, E. E., & Gilbert, A. L. (2007). Pharmaceutical brand substitution in Australia : are there multiple switches per prescription?. Australian and New Zealand Journal of Public Health, 31(4), 348-352.
DOI Scopus11 WoS9 Europe PMC4
2007 Kalisch, L. M., Roughead, E. E., & Gilbert, A. L. (2007). Do pharmacists adhere to brand substitution guidelines? The example of simvastatin. Journal of pharmacy practice and research, 37(4), 292-294.
DOI
2006 Morgan, S., McMahon, M., Mitton, C., Roughead, E. E., Kirk, R., Kanavos, P., & Menon, D. (2006). Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom. Health affairs, 25(2), 337-347.
DOI WoS77 Europe PMC71
2006 Roughead, E. E. (2006). Enhancing early uptake of drug evidence into primary care. Expert review of pharmacoeconomics and outcomes research, 6(6), 661-671.
DOI
2006 Roughead, E. E., Zhang, F., Ross Degnan, D., & Soumerai, S. (2006). Differential effect of early or late implementation of prior authorization policies on the use of cox II inhibitors. Medical care, 44(4), 378-382.
DOI
2006 Roughead, E. E., & Lexchin, J. (2006). Adverse drug events. Medical journal of Australia.
2006 Zerzan, J., Morden, N., Soumerai, S., Ross Degnan, D., Roughead, E. E., Zhang, F., . . . Sullivan, S. (2006). Trends and geographic variation of opiate medication use in state medicaid fee-for-service programs, 1996 to 2002. Medical Care, 44(11), 1005-1010.
DOI
2005 Dollman, W. B., LeBlanc, V., Stevens, L., OConnor, P., Roughead, E. E., & Gilbert, A. L. (2005). Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach. Journal of Clinical Pharmacy and Therapeutics.
2005 Semple, S. J., & Roughead, E. E. (2005). Reducing medication error and harm: an important role for pharmacy in medication safety and safer systems. Australian Pharmacist.
2005 Roughead, E. E. (2005). Managing adverse drug reactions: time to get serious. Medical Journal of Australia, 182(6), 264-265.
2005 Kirkpatrick, C., Roughead, E. E., Monteith, G., & Tett, S. (2005). Consumer involvement in Quality Use of Medicines (QUM) projects : lessons from Australia. BMC health services research, 5(1).
DOI
2005 Roughead, E. E., Semple, S. J., & Vitry, A. I. (2005). Pharmaceutical care services: a systemic review of published studies 1990 to 2003, examining effectiveness in improving patient outcomes. International journal of pharmacy practice, 13(1), 53-70.
DOI
2005 Harvey, K., Vitry, A. I., Roughead, E. E., Aroni, R., Ballenden, N., & Faggotter, R. (2005). Pharmaceutical advertisements in prescribing software. Medical journal of Australia.
2004 Roughead, L., & Semple, S. (2004). Building a safer system for Australian health care: essential role of clinical pharmacy services. Journal of Pharmacy Practice and Research, 34(2), 88-89.
2004 Roughead, E. E., McGeechan, K., & Sayer, G. (2004). Bisphosphonate use and subsequent prescription of acid suppressants. British Journal of Clinical Pharmacology.
2004 Roughead, E. E., Barratt, J. D., & Gilbert, A. L. (2004). Medication-related problems commonly occurring in an Australian community setting. Pharmacoepidemiology and drug safety, 13(2), 83-87.
DOI
2003 Dollman, W. B., LeBlanc, V., & Roughead, E. E. (2003). Managing insomnia in the elderly : what prevents us using non-drug options?. Journal of Clinical Pharmacy and Therapeutics, 28(6), 485-491.
DOI
2003 Roughead, E. E., Semple, S. J., & Gilbert, A. L. (2003). Quality use of medicines in aged-care facilities in Australia. Drugs and aging, 20(9), 643-653.
DOI
2003 Dollman, W. B., LeBlanc, V., Stevens, L., & Roughead, E. E. (2003). Facilitating better management of insomnia in the elderly. Australian Pharmacist.
2003 Runciman, W., Roughead, E., Semple, S., & Adams, R. (2003). Adverse drug events and medication errors in Australia. International Journal for Quality in Health Care, 15(Supplement 1), i49-i59.
DOI Scopus300 WoS223 Europe PMC187
2002 Gilbert, A., Roughead, E., Beilby, J., Mott, K., & Barratt, J. (2002). Collaborative medication management services: improving patient care. Medical Journal of Australia, 177(4), 189-192.
DOI Scopus131 Europe PMC86
2002 Lee, L. M., Roughead, E. E., Gilbert, A. L., Cosh, D., Nation, R., Barnes, L., . . . Ballantyne, A. (2002). Crushing or altering medications: what's happening in residential aged-care facilities?. Australasian journal on ageing.
2002 Gilbert, A. L., Roughead, E. E., & Sansom, L. N. (2002). I've missed a dose; What should I do?. Australian Prescriber.
2002 Szeto, M. P., Semple, S. J., & Roughead, E. E. (2002). A study of complementary medicine advertising in Australia. Australian Pharmacist.
2002 Roughead, E. E., & Gilbert, A. L. (2002). Medication misadventure. Australian Pharmacist.
2002 Gilbert, A. L., Roughead, E. E., Beilby, J., Mott, K., & Barratt, J. D. (2002). Collaborative medication management services. Medical journal of Australia.
2000 Roughead, E. E., & Tett, S. (2000). Quality use of medicines - onwards up the pyramid. The Australian Journal of Hospital Pharmacy.
2000 Roughead, E. E., & Gilbert, A. L. (2000). Medicine and the media. Australian Prescriber, 23(6), 115.
DOI
1999 March, G. J., Gilbert, A. L., Roughead, E. E., & Quintrell, N. (1999). Developing and evaluating a model for pharmaceutical care in Australian community pharmacies. International journal of pharmacy practice.
1999 Roughead, E. E. (1999). The nature and extent of drug-related hospitalisations in Australia. Journal of Quality in Clinical Practice.
1999 Halstead, P. J., Roughead, E. E., Rigby, K., Clark, K., & Gallas, A. (1999). Towards the safer use of warfarin II: Results of a workshop. Journal of Quality in Clinical Practice.
1999 Roughead, E. E., Gilbert, A. L., & Primrose, J. (1999). Improving drug use. Social science and medicine.
1999 Roughead, E. E. (1999). The Australian Pharmaceutical Manufacturers association Code of Conduct: Guiding the promotion of prescription medicines. Australian prescriber.
1999 Day, R., Rowett, D., & Roughead, E. E. (1999). Towards the safer use of non-steroidal anti-inflammatory drugs. Journal of Quality in Clinical Practice.
1998 Roughead, E. E., Gilbert, A. L., Primrose, J., & Sansom, L. N. (1998). Drug-related hospital admissions. Medical journal of Australia.
1998 Roughead, E. E., & Gilbert, A. L. (1998). Australian trends in hospitalisation and mortality associated with chronic health failure. Medical journal of Australia.
1998 Roughead, E. E., Harvey, K., & Gilbert, A. L. (1998). Self-regulatory codes of conduct. International Journal of Health Services, 28(2), 269-279.
DOI
1998 Roughead, E. E., Gilbert, A. L., & Harvey, K. (1998). Commercial detailing techniques used by pharmaceutical representatives to influence prescribing. Australian and New Zealand Journal of Medicine, 28(3), 306-310.
DOI
1998 Roughead, E. E., Gilbert, A. L., Primrose, J., & Sansom, L. N. (1998). Coding drug-related admissions in medical records: Is it adequate for monitoring the quality of medicine use.. Australian journal of hospital pharmacy.

Year Citation
2024 Pont, L. G., Nguyen, T. A., & Roughead, E. (2024). Drug utilization research in the Western Pacific Region. In M. Elseviers (Ed.), Source details - Title: Drug Utilization Research: Methods and Applications (pp. 557-562). US: John Wiley & Sons.
DOI
2023 Roughead, E., Dorj, G., & Lim, R. (2023). Experimental approaches and generating the evidence. In D. Stewart, & Z. -U. -D. Babar (Eds.), Source details - Title: Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy (pp. 1-17). Singapore: Springer.
DOI
2018 Nguyen, T. A., & Roughead, E. (2018). Strengths and weaknesses of pharmaceutical policy in relation to rational and responsible medicines use. In M. I. M. Ibrahim, A. I. Wertheimer, & Z. U. D. Babar (Eds.), Source details - Title: Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries: Present Challenges and Future Solutions (pp. 247-262). US: Academic Press.
DOI Scopus1
2017 Nguyen, T. A., Vitry, A., & Roughead, E. E. (2017). Pharmaceutical policy in Vietnam. In Z. Babar (Ed.), Source details - Title: Pharmaceutical policy in countries with developing healthcare systems (1 ed., pp. 75-96). Switzerland: ADIS - Springer International Publishing.
DOI Scopus10
2015 Nguyen, T. A., & Roughead, E. (2015). Pharmaceutical pricing policies in Vietnam. In Z. Babar (Ed.), Source details - Title: Pharmaceutical prices in the 21st century (pp. 321-342). Germany: Springer International.
DOI Scopus9
2015 Roughead, E., & Gilbert, A. (2015). Development, delivery and evaluation of implementation programmes. In M. Elseviers (Ed.), Source details - Title: Drug utilization research: methods and applications (pp. 468-476). US: Wiley-Blackwell.
2015 Vitry, A. I., Thai, L., & Roughead, E. E. (2015). Pharmaceutical pricing policies in Australia. In Z. U. D. Babar (Ed.), Source details - Title: Pharmaceutical prices in the 21st century (pp. 1-23). Germany: Springer.
DOI
2012 Kemp, A., Preen, D. B., Sanfilippo, F. M., Glover, J., Semmens, J., & Roughead, E. E. (2012). Evaluating pharmaceutical policy impacts using interrupted time series analysis. In E. Bell, G. P. Westert, & J. Merrick (Eds.), Source details - Title: Translational research for primary healthcare (pp. 73-87). US: Nova Science Publishers.

Year Citation
2024 Chan, A., Bahmanyar, S., Bushnell, G. A., Carleton, B., Chan, A. H. Y., Cook, S., . . . Wong, I. C. K. (2024). Multinational Prescribing Trends of Lithium From 2001-2019: A Retrospective Observational Study Using Population-Based Databases From 17 Countries and One Special Administrative Region. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 33 (pp. 518-519). WILEY.
2022 Hillen, J., Duszynski, K., Stanford, T., Ward, M., Roughead, E., Kalisch, L., & Pratt, N. (2022). Application of a systems biology approach to address confounding by indication for immune-mediated disorders in spontaneous reports data: A case study of vedolizumab-associated pancreatitis in inflammatory bowel disease. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 31 (pp. 79). WILEY.
2021 Hillen, J., Ward, M., Slee, M., Stanford, T., Roughead, E. E., Kalisch-Ellett, L., & Pratt, N. (2021). Utilisation and treatment patterns of medicines to manage relapsing remitting multiple sclerosis: Implications for pharmacovigilance. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 30 (pp. 390). WILEY.
2020 Kubota, K., Kelly, L., Sato, T., Pratt, N., Roughead, L., & Yamaguchi, T. (2020). A weighting method to remove bias from within-subject exposure dependency in case-crossover studies. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 29 (pp. 359-360). WILEY.
2019 Kassie, G., Woodward, M., Ellett, L. K., Nguyen, T., & Roughead, E. (2019). Medicines, delirium and hospitalisation: Can we do better?. In AUSTRALASIAN JOURNAL ON AGEING Vol. 38 (pp. 26-27). WILEY.
2019 Lim, R., Roughead, E. E., Ramsay, E., Moffat, A., & Pratt, N. (2019). PERSISTENCE WITH OPIOIDS POST DISCHARGE FROM HOSPITALISATION FOR SURGERY IN AN AUSTRALIAN ADULT COHORT. In RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY Vol. 15 (pp. E14). ELSEVIER SCIENCE INC.
2017 Raman, S. R., Man, K. K. C., Bahmanyar, S., Bushnell, G., KaoYang, Y. -H., Karlstad, O., . . . Wong, I. C. K. (2017). Utilization of Attention Deficit Hyperactivity Disorder Medications (ADHD) by Adults in 13 Countries. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 26 (pp. 333). WILEY.
2017 Rasmussen, L., Hansen, M. R., Pratt, N., Roughead, L., Hallas, J., & Pottegard, A. (2017). The Proportion of Patients Covered (PPC) Method. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 26 (pp. 239). WILEY.
2017 Leach, M. J., Pratt, N. L., & Roughead, E. (2017). The Risk of Hip Fracture in Older People After Switching Between or Concurrently Using Mirtazapine and Other Antidepressants. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 26 (pp. 164). WILEY.
2017 Roughead, E. E., Pratt, N. L., Ellett, L. M. K., Ramsay, E. N., Barratt, J. D., Morris, P., & Killer, G. (2017). Post-Traumatic Stress Disorder, Antipsychotic Use and Risk of Dementia in Veterans. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 26 (pp. 455-456). WILEY.
2016 Gillam, M. H., Inacio, M. C. S., Pratt, N. L., & Roughead, E. E. (2016). Magnetic Resonance Imaging Examination in People with Cardiac Implantable Electronic Devices. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 25 (pp. 125-126). WILEY-BLACKWELL.
2016 Gillam, M., Pratt, N., Graves, S., & Roughead, E. (2016). Heart Failure After Conventional Large Head Metal-On-Metal Hip Replacements In Men. In INTERNAL MEDICINE JOURNAL Vol. 46 (pp. 19). WILEY-BLACKWELL.
DOI
2016 Inacio, M. C. S., Hansen, C., Roughead, E. E., Pratt, N. L., & Graves, S. E. (2016). Risk Factors for Persistent and New Chronic Opioid Use in Patients Undergoing Total Hip Arthroplasty. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 25 (pp. 63-64). WILEY-BLACKWELL.
2015 Inacio, M. C. S., Namba, R. S., Pratt, N. L., Graves, S. E., Roughead, E. E., Cheetham, C. T., & Paxton, E. W. (2015). Opioid Use as an Early Indication of Total Knee Arthroplasty Failure. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 24 (pp. 296-297). WILEY-BLACKWELL.
2015 Shin, J. -Y., Lee, S. H., Shin, H. N., Choi, S. -H., Pratt, N. L., Roughead, E. E., & Park, B. -J. (2015). Cardiac Risk Associated with Methylphenidate in Pediatric Patients with Attention Deficit Hyperactivity Disorder (ADHD): Self-controlled Case Series Study in Korea. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 24 (pp. 235-236). WILEY-BLACKWELL.
2015 Pratt, N. L., Ellett, L. M. K., Sluggett, J. K., Ramsay, E. N., Kerr, M., LeBlanc, V. T., . . . Roughead, E. E. (2015). Improving Use of Medicines by Using Commitment Questions in Patient Response Forms: An Evaluation. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 24 (pp. 65). WILEY-BLACKWELL.
2014 Leach, M. J., Pratt, N. L., & Roughead, E. E. (2014). Medicine Use and the Risk of Hip Fracture in the Elderly: A Case-Crossover Study. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 23 (pp. 180-181). WILEY-BLACKWELL.
2014 Le Blanc, V. T., Gilbert, A. L., Ellett, L. K., Pratt, N. L., Barratt, J. D., Ramsay, E. N., . . . Roughead, E. E. (2014). Using Routinely Collected Administrative Health Claims Data to Improve the Uptake of Primary Healthcare Services. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 23 (pp. 131-132). WILEY-BLACKWELL.
2013 Lai, E. C. -C., Shin, J. -Y., Ooba, N., Pratt, N., Yang, Y. -H. K., Park, B. J., . . . Setoguchi, S. (2013). Comparative Safety of Nonsteroidal Anti-Inflammatory Drugs Commonly Used in Asia-Preliminary Findings from Asian Pharmacoepidemiology Network (AsPEN) Association Study. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 22 (pp. 9). WILEY-BLACKWELL.
2013 Pratt, N., Wahab, I., Kalish, L., & Roughead, E. (2013). Validation of Sequence Symmetry Analysis as a Tool for Rapid Safety Signal Detection: A Simulation Study of Newly Marketed Medicines. In DRUG SAFETY Vol. 36 (pp. 848). Pisa, ITALY: ADIS INT LTD.
2013 Roughead, E., Wahab, I., Kalisch, L., & Pratt, N. (2013). Sequence Symmetry Analysis: A Valid Tool with Potential to Enable Global Pharmacosurveillance. In DRUG SAFETY Vol. 36 (pp. 815). Pisa, ITALY: ADIS INT LTD.
2013 Woodward, M., Ellett, L. K., LeBlanc, V., & Roughead, E. (2013). How well do we monitor renal function in the elderly when prescribing?. In AUSTRALASIAN JOURNAL ON AGEING Vol. 32 (pp. 29). WILEY-BLACKWELL.
WoS1
2012 Gilbert, A., Roughead, E., Avorn, J., Andersen, M., & Caughey, G. (2012). Pharmacoepidemiology: The Essential Discipline in the Provision of Safe and Effective Care for Older Patients with Multimorbidity. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 193-194). WILEY PERIODICALS, INC.
2012 Caughey, G. E., Preiss, A. K., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2012). Antidepressants and Risk of Discontinuation of Diabetes Medicines. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 188). WILEY PERIODICALS, INC.
2012 Gadzhanova, S., Bell, S., & Roughead, E. (2012). Oxycodone Use in Australian Veterans at Risk of Respiratory Depression. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 77-78). WILEY PERIODICALS, INC.
2012 Ilomaki, J., Gadzhanova, S., & Roughead, E. E. (2012). COX-2 and Non-Selective NSAID Use in Those at Increased Risk of NSAID-Related Adverse Events. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 21 (pp. 70). WILEY PERIODICALS, INC.
2011 Woodward, M., Pratt, N., Le Blanc, V., Ryan, P., Salter, A., & Roughead, E. (2011). Are antipsychotics safe in the elderly?. In INTERNATIONAL PSYCHOGERIATRICS Vol. 23 (pp. S136). CAMBRIDGE UNIV PRESS.
2010 Kemp, A., Roughead, E. E., Preen, D. B., Glover, J., & Semmens, J. (2010). Low Income Workers Face the Largest Cost Burden for Prescription Medicines in Australia. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 19 (pp. S219). Brighton, ENGLAND: WILEY-BLACKWELL.
2010 Caughey, G., Roughead, E., Pratt, N., Shakib, S., Vitry, A., & Gilbert, A. (2010). Adverse Outcomes Associated with Potential Prescribing Cascades. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 19 (pp. S130-S131). Brighton, ENGLAND: WILEY-BLACKWELL.
2010 Pratt, N. L., Roughead, L. E., Peck, R., & Andrew, G. (2010). Self-Controlled Case Series and Prescription Event Symmetry Analysis: How Different Are They Really?. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 19 (pp. S229). Brighton, ENGLAND: WILEY-BLACKWELL.
2009 Caughey, G., Vitry, A., Gilbert, A., & Roughead, E. (2009). Polypharmacy in Chronic Diseases in the Elderly: Evidence-Based or Potentially Inappropriate Prescribing?. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 18 (pp. S197-S198). JOHN WILEY & SONS LTD.
2009 Vitry, A., Roughead, E., Ramsay, E., Preiss, K., Ryan, P., Esterman, A., . . . Caughey, G. (2009). Risk in older patients of major bleeding associated with warfarin when other medicines are co-prescribed for concomitant medical conditions. In AUSTRALASIAN JOURNAL ON AGEING Vol. 28 (pp. A119). WILEY-BLACKWELL PUBLISHING, INC.
2008 Vitry, A. I., Wong, S. A., Roughead, E. E., & Ramsay, E. (2008). Validity of medication-based comorbidity indices in the Australian elderly population. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 17 (pp. S88). JOHN WILEY & SONS LTD.
2007 Kalisch, L., Roughead, E., & Gilbert, A. (2007). Brand and generic substitution in Australia: Are patients switched between products multiple times?. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 16 (pp. S55-S56). WILEY.
2007 Hennessy, S., Leonard, C. E., & Bilker, W. B. (2007). Researchers were able to obtain 78% of requested hospital records to validate medicaid and medicare claims while complying with HIPAA. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 16 (pp. S232-S233). WILEY.
DOI
2007 Pratt, N., Roughead, E., Peck, R., & Gilbert, A. (2007). Validation of an Australian claims database to detect adverse events post drug therapy. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 16 (pp. S195). WILEY.
2006 Gilbert, A. L., Roughead, E., Pratt, N., & Peck, R. (2006). Using an Australian linked health dataset to assist medical practitioners manage therapeutic risk: The Veterans' MATES project. In PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Vol. 15 (pp. S140). JOHN WILEY & SONS LTD.
2006 Roughead, E. E. (2006). Australia's national medicines policy. In Congressional staff briefing - reviewing prescription drug coverage, policies and practice across several health systems.. Washington, DC: Alliance for Health Reform.
2005 Roughead, E. E., Seddon, M., Morgan, S., & Kanavos, P. (2005). Pharmaceutical policy supporting sustainable access to necessary medicines to improve health outcomes. In 1st Alumni Health Policy conference. Bagshot, England.
2005 Gilbert, A. L., & Roughead, E. E. (2005). Using health data sets to improve and evaluate medicine and health services use: veterans mates project. In Joanna Briggs Institute Conference - Pebbles of Knowledge Making Evidence Meaningful.
2005 Hughes, C., Roughead, E. E., & Kerse, N. (2005). Beyond regulation: international strategies to improve use of medicines, with examples from long-term care. In 1st Alumni Health Policy conference. Bashot, England.
2004 Roughead, E. E. (2004). The national medicines policy - 2004 and beyond. In The Society of Hospital Pharmacists of Australia: Quality Use of Medicines 2004 and Beyond. Phillip Island: Society of Hospital Pharmacists of Australia.
2004 Roughead, E. E. (2004). Australia's national strategy for quality use of medicines: translating policy and research into a national program. In 8th World Conference on Clinical Pharmacology and Therapeutics. Brisbane: Blackwell.
2002 Roughead, E. E., & Semple, S. J. (2002). Safety and Quality Council - Second National Report on Patient Safety. In Improving Medication Safety. Canberra: Commonwealth Department of Health and Ageing.
2001 Barratt, J. D., Roughead, E. E., & Gilbert, A. L. (2001). Characterisation of Medication-related Problems Amongst a Sample of Older Persons Living in the Community. In Proceedings of the Australasian Pharmaceutical Science Association.
2001 Williams, D. B., & Roughead, E. E. (2001). Achieving Quality use of Medicines in Australia. In Better Health through Pharmacy Network.
2001 Szeto, P., Semple, S. J., & Roughead, E. E. (2001). A Study of Complementary Medicine Advertising in Australia. In Proceedings of the Australasian Pharmaceutical Science Association. Melbourne, Victoria, Australia: APSA.
2001 Misan, G., Lowings, C., CAYETANO, T. N., Wilkinson, D., Roughead, E. E., Morton, P., & Stamoulis, J. (2001). The Whyalla quality use of medicines project - A whole-of-community model for sustainable QUM activity. In The Sociey of Hospital Pharmacists of Australia.
2001 Roughead, E. E., & Williams, D. B. (2001). Achieving Quality use of Medicines. In Proceeding Pharma Indochina II.
2000 Tett, S., Roughead, E. E., Monteith, G., & Harvey, K. (2000). Australia's National Medicinces Policy - collating and evaluating the information from QUMMAP.HEALTH.GOV.AU. In Proc. Soc. Hosp. Pharm. Aust..
2000 Roughead, E. E. (2000). Australia's national Medicines Policy: Providing a vision for the future. In APSA.
2000 Roughead, E. E., & Tett, S. (2000). National medicines policy evaluation using QUMMAP.HEALTH.GOV.AU. In APSA.
2000 Tett, S., Roughead, E. E., Monteith, G., & Harvey, K. (2000). Using th einternet to evaluate National Medicines Policy. In Proc. Aust Clinical Exp. Pharmacol. Toxicology.
1999 Roughead, E. E., & Manteith, G. (1999). Evaluating Australia's National Medicinal Drug Policy. In Proceedings of ASCEPT - Australian Society of Clinical and Experimental Toxicologists. Sydney: ASCEPT.
1999 Roughead, E. E., Tett, S., Manteith, G., & Harvey, K. (1999). The Quality Use of Medicines Mapping Project. In Quality Use of Medicines Conference. Brisbane: Queensland Health.
1999 Roughead, E. E., & Hunt, S. (1999). Mapping Project incorporating quality use of medicines in aged care (Quality Use of medicines in Australia). In Looking forward - A new century of change and challenge. Royal College of Nursing, Australia. Canberra: Royal College of Nursing, Australia.
1998 Roughead, E. E., Gilbert, A. L., Primrose, J., & Sansom, L. N. (1998). Quality Use of medicines in Australia: How far have we come and where are we going?. In Proceedings of ASCEPT. ASCEPT.
1997 Sansom, L. N., Gilbert, A. L., Primrose, J., & Roughead, E. E. (1997). The development of outcome indicators for Australia's policy on the quality use of medicines. In Conference Proceedings: Austalasian Pharmaceutical Sciences Association.
- Leach, M. J., Pratt, N. L., & Roughead, E. E. (n.d.). THE RISK OF HIP FRACTURE IN OLDER PEOPLE USING SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) AND OTHER PSYCHOACTIVE MEDICINES CONCURRENTLY. In RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY Vol. 13 (pp. E30). ELSEVIER SCIENCE INC.

Year Citation
2021 Nguyen, T. A., Tran, K., Hinton, L., Roughead, E. E., Esterman, A., Dang, T. H., . . . Brodaty, H. (2021). Life experiences of people with dementia in Vietnam and among the Vietnamese diaspora: a systematic review of qualitative studies. Poster session presented at the meeting of Alzheimer's & dementia : the journal of the Alzheimer's Association. US: John Wiley & Sons, Inc..
DOI
2018 Reddel, H. K., Laba, T., Jan, S., Marks, G. B., Flynn, A., Roughead, E., . . . Zwar, N. (2018). Effects of out-of-pocket costs on patient adherence with asthma medicines. Poster session presented at the meeting of American Thoracic Society 2018 International Conference. US: American Thoracic Society.
2017 Preen, D., Kemp Casey, A., Roughead, E., Lopez, D., Bulsara, M., Boyle, F., & Saunders, C. (2017). Determining breast cancer recurrence following completion of active treatment: a novel approach using linked administrative health data. Poster session presented at the meeting of International Journal of Population Data Science. UK: Swansea University.
DOI Europe PMC1
2017 Pratt, N., Lai, E. C. C., Pottegard, A., Roughead, E., & Hallas, J. (2017). A practical guide to implementing sequence symmetry analysis; a tool for conducting studies in the Asian Pharmacoepidemiology Network (AsPEN). Poster session presented at the meeting of Pharmacoepidemiology and drug safety. UK: John Wiley and Sons.
DOI
2017 Caughey, G. E., Gadzhanova, S., Shakib, S., & Roughead, E. E. (2017). Trends in Concomitant Prescribing of Opioids and Benzodiazepines in Australia 2010-2015; a Cause for Concern?. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY.
2017 Ramsay, E., Pratt, N., Ellett, L. K., Shakib, S., Caughey, G., Kemp-Casey, A., & Roughead, E. (2017). Post-Market Surveillance of Aflibercept for Macular Degeneration. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY.
2016 Caughey, G. E., Barratt, J. D., Shakib, S., Kemp-Casey, A., & Roughead, E. E. (2016). Medication Use and Potentially High Risk Prescribing in Older Patients Hospitalised for Diabetes: A Missed Opportunity to Improve Care?. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL.
2014 Pratt, N., Ramsay, E., Kemp, A., Ellett, L. K., Shakib, S., Caughey, G., . . . Roughead, E. (2014). Ranibizumab Associated with Increased Risk of Ischaemic Stroke but Not Myocardial Infarct: A Self-Controlled Case Series Analysis. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL.
2013 Woodward, M., Pratt, N., Leblanc, V., Barratt, J., Ramsay, E., Tuan, N., & Roughead, E. (2013). What is the impact of taking multiple psychotropic medicines on the risk of falling?. Poster session presented at the meeting of International Psychogeriatrics. UK: Cambridge University Press.
2011 Ramsay, E., Pratt, N. L., Roughead, E., Ryan, P., & Ewald, B. (2011). A Self-Controlled Case Series To Assess the Effectiveness of Beta Blockers for Heart Failure in Reducing Hospitalisations in the Elderly. Poster session presented at the meeting of PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. WILEY-BLACKWELL.
2011 Caughey, G. E., Preiss, A. K., Vitry, A. I., Gilbert, A. L., & Roughead, E. E. (2011). Increased risk of hospitalisation with corticosteroid use in patients with diabetes and COPD. Poster session presented at the meeting of Pharmacoepidemiology and drug safety. UK: WILEY-BLACKWELL.
2008 Caughey, G., Vitry, A., Gilbert, A., & Roughead, E. E. (2008). Concomitant chronic medication prescribing in the elderly. Poster session presented at the meeting of National Medicines Symposium 2008. Australia.

Year Citation
- Preiss, K., Pratt, N., & Roughead, L. (n.d.). Dataset associated with Sequence Symmetry Analysis Graphic Adjustment for Prescribing Trends.
DOI

  • HEAD Deed: RFQ Therapeutic Goods Evaluation and Advice Panel, Cwth Dept of Health Aged Care, 30/07/2024 - 30/06/2027

  • Veterans' Medicines Advice and Therapeutics Education Services (Veterans' MATES) Program, Cwth Dept of Veterans' Affairs, 01/09/2015 - 30/06/2027

  • Enhancing mental health care through a real-time Quality Use of Medicines (QUM) data analytics dashboard in acute mental health hospitals, Cwth Dept of Foreign Affairs and Trade, 22/07/2024 - 21/07/2026

  • Analysis of PBS data for National Report on Antimicrobial Use and Resistance 2024, Australian Commission on Safety and Quality in Health Care, 17/04/2025 - 31/08/2025

  • QUM in Schools and Childcare settings, Australian Commission on Safety and Quality in Health Care, 02/12/2024 - 30/04/2025

  • Medication Safety in Children: Literature review, Pharmaceutical Society of Australia, 23/07/2024 - 28/02/2025

  • Turning antimicrobial resistance in residential aged care inside-out from the patient to facility level, MRFF - Targeted Call for Research - Antimicrobial Resistance, 26/06/2018 - 30/06/2024

  • Quality Use of Medicines Literature Review PH23/5815, Cwth Dept of Health Aged Care, 22/06/2023 - 17/05/2024

  • Large scale evidence generation for the utilisation and safety of biologic medicines, NHMRC - Project Grant, 01/01/2019 - 31/12/2023

  • Strengthening responses to dementia: Building an evidence platform for the development of a Vietnam National
Dementia Plan, NHMRC-NAFOSTED Joint Call for Collaborative Research Projects, 01/04/2019 - 31/03/2022

  • Veterans' Medicines Advice and Therapeutics Education Services (Veterans' MATES) Program, Cwth Dept of Veterans' Affairs, 01/09/2015 - 31/12/2021

  • Using Big Data to improve medication use and safety, NHMRC - Research Fellowship, 01/01/2016 - 31/12/2021

  • Establishment of a health data analytics panel, Cwth Dept of Health Aged Care, 01/09/2016 - 08/12/2021

  • Utilisation review of prostacyclin analogue medicines for the treatment of pulmonary arterial hypertension (PAH), Cwth Dept of Health Aged Care, 26/03/2021 - 15/10/2021

  • PBS/RPBS Data Analysis and Report for the Antimicrobial use and resistance in Australia (AURA) Program, Australian Commission on Safety and Quality in Health Care, 21/01/2021 - 30/06/2021

  • ReMinDAR Trial: Reducing medicine induced deterioration and adverse reactions trial, Cwth Dept of Health Aged Care, 15/09/2017 - 31/03/2021

  • Why is there an increased risk of severe adverse perinatal outcomes after the use of clomiphene citrate for infertility treatment?, NHMRC - Project Grant, 01/01/2018 - 31/12/2020

  • How best to protect public health: a comparative analysis of regulatory safety warnings on medicines in
Australia, Canada the European Union and the United States, NHMRC - Project Grant, 01/01/2017 - 31/12/2020

  • CVC Mental Health Pilot, Cwth Dept of Veterans' Affairs, 03/01/2018 - 31/12/2020

  • Centre of Research Excellence in post-market surveillance of medicines and medical devices, NHMRC - Centre of Research Excellence, 01/11/2012 - 31/10/2018

Date Role Research Topic Program Degree Type Student Load Student Name
2023 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mr Lasantha Ranwala Arachchige Don
2022 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Mr Huri Balikubiri
2022 Principal Supervisor - Doctor of Philosophy Doctorate Full Time Mr Abebe Basazn Mekuria
2021 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Mr Netsanet Bogale Kumsa
2016 Co-Supervisor - Doctor of Philosophy Doctorate Full Time Miss Courtney Elise De Vries

Date Role Research Topic Program Degree Type Student Load Student Name
2015 - 2018 External Supervisor The effects of pharmacist prescribing on patient outcomes in the hospital setting: A systematic review Master of Clinical Science Master Part Time Ms Eng Whui Poh
2007 - 2010 External Supervisor Medication Prescribing in the Elderly and the Effect on Health Related Outcomes: An Investigation of Bias in Observational Studies using Computerised Claims Databases Doctor of Philosophy Doctorate Full Time Ms Nicole Pratt

Date Role Board name Institution name Country
2024 - ongoing Chair International Society to Improve Use of Medicines International Society to Improve Use of Medicines Australia

Date Role Committee Institution Country
2024 - ongoing Member Medication Safety And Quality Advisory Committee Australian Commission on Safety and Quality in Health Care Australia
2001 - ongoing Member Drug Utilisation Subcommittee of the Pharmaceutical Benefits Advisory Committee Australian Government Department of Health, Ageing and Disability Australia

Date Role Editorial Board Name Institution Country
2012 - 2022 Associate Editor Pharmacoepidemiology and Drug Safety International Society for Pharmacoepidemiology United States

Connect With Me

External Profiles

Other Links